Abstract

An iPrMgCl-deprotonating Weinreb amide-type Horner–Wadsworth–Emmons (HWE) reaction was developed, and the effects of diverse reaction conditions, including the base, cation, solvent, and concentration, were investigated to broaden the substrate scope and achieve high (E)-selectivity. The Weinreb amide-type phosphonoenolate generated from iPrMgCl was found to be isolable, stable for at least over a half year, and applicable in the HWE reaction keeping high productivity and selectivity compared with the in situ generated phosphonoenolate. The results prompted us to perform an application study including successive elongation, synthesis of a biscyclopropane, and Weinreb ketone syntheses.
Introduction
The Horner–Wadsworth–Emmons (HWE) reaction is a ubiquitous reaction in organic synthesis. It was discovered by Horner and co-workers in 1958 as a modification of the Wittig reaction1 and further developed by Wadsworth, Emmons, and co-workers in 1961.2 Subsequently, many researchers have investigated various types of phosphonate-type elongation reagents,3 which have been called HWE reagents. The numerous reports on the HWE reaction in organic synthesis demonstrate its important role in this field.4 Therefore, the development of highly selective, robust, and scalable synthetic methods with broad substrate scope based on the HWE reaction constitutes an active area of research. Considering that Weinreb amides can be easily transformed not only to aldehydes by reduction, which prevents over-reduction to alcohol, but also to ketones by nucleophilic addition of alkyl lithium and Grignard reagents,5 α,β-unsaturated Weinreb amides are attractive building blocks and functional moieties in organic synthesis. A Weinreb amide-type HWE reagent was first reported by Nuzillard in 1989,6 and it was further developed by Seidel in 19927 (Scheme 1). After 10 years of Seidel’s report, in 2002, Deslongchamps and co-workers reported the Still–Gennari-type (Z)-selective HWE reaction.3al
Scheme 1. First Report of Weinreb Amide-Type HWE Reagent.

Nuzillard reported an (E)-selective HWE reaction using n-butyl lithium (nBuLi) as a phosphonoenolate-generating reagent (Scheme 1A). Meanwhile, Seidel reported two conditions for the (E)-selective HWE reaction (Scheme 1B), i.e., using sodium hydride (NaH) as a phosphonoenolate-generating reagent and the Masamune–Roush’s Lewis acid combination conditions. However, despite their efforts, broadening of the substrate scope is still required, and the reason for the selectivity reported by Nuzillard’s remains unclear. In 2008, Davies and co-workers reported that in the case of ethyl ester-type HWE reagents, methyl magnesium bromide (MeMgBr) was very effective for obtaining satisfactory (E)-selectivity and reactivity,8,9 whereas nBuLi gives low (E)-selectivity with aliphatic aldehydes. Nevertheless, no report has addressed the effect of different reaction conditions on the HWE reaction using the same substrate. Therefore, with the aim of unveiling the question about the selectivity of the HWE reaction and developing a robust and highly selective Weinreb amide-type HWE reaction with broad substrate scope, we investigated the effect of the reaction conditions on the reactivity and selectivity of the Weinreb amide-type HWE reaction.
Results and Discussion
To verify Nuzillard’s and Davies’ argument about the reaction selectivity, we first replicated Nuzillard’s reaction conditions, that is, nBuLi as the phosphonoenolate-generating reagent, −78 °C as the reaction temperature, and a Weinreb amide-type HWE reagent as an elongation reagent, using heptanal and benzaldehyde as substrates, which were employed in Nuzillard’s and Seidel’s reports (Table 1).
Table 1. Comparison of Nuzillard’s Original Data with Our Results Employing Nuzillard’s Conditions.
Our results revealed that Nuzillard’s conditions gave no selective reaction products in the case of heptanal (Table 1, entry 1), which is consistent with Davies’ report but not with Nuzillard’s original data. In this case, the reaction time did not affect the selectivity (Table 1, entry 2). To confirm this selectivity trend in the case of aliphatic aldehydes, we employed 3-phenypropanal as a typical aliphatic substrate commonly used in this research area. Again, no selective reaction products were obtained (Table 1, entry 6), confirming the selectivity trend described by Davies.10 Meanwhile, benzaldehyde as a representative aromatic aldehyde afforded (E)-5b with high (E)-selectivity under Nuzillard’s conditions (Table 1, entries 3 and 5), in consistency with Davies’ and Nuzillard’s reports. According to the results of the HWE reaction of aliphatic aldehydes, the development of an (E)-selective HWE reaction suitable for a wide range of aliphatic aldehydes was required. Thus, we tackled the optimization of the Weinreb amide-type HWE reaction conditions.
Effect of Strong Base Conditions and Cation on the Yield and Selectivity of the Weinreb Amide-Type HWE Reaction
To further investigate the selectivity of the Weinreb amide-type HWE reaction, we evaluated various strong base conditions using 3-phenylpropanal as the substrate (Table 2).
Table 2. Effect of Strong Base Conditions, Cation, and Temperature on the Weinreb Amide-Type HWE Reaction.
| Yield (%) |
||||||
|---|---|---|---|---|---|---|
| Entry | Base | Temperature | Time | (E)-5c | (Z)-5c | E/Z |
| 1 | LHMDS | –78 °C | 20 min | 27 | 41 | 40/60 |
| 2 | LHMDS | 0 °C | ↑ | 74 | 18 | 80/20 |
| 3 | LHMDS | rt | ↑ | 73 | 13 | 85/15 |
| 4 | LHMDS | –78 °C to rt | ↑ | 44 | 47 | 49/51 |
| 5 | NaHMDS | 0 °C | ↑ | 85 | 3 | 97/3 |
| 6 | NaHMDS | rt | ↑ | 84 | 4 | 95/5 |
| 7 | KHMDS | 0 °C | ↑ | 77 | 10 | 88/12 |
| 8 | KHMDS | rt | ↑ | 79 | 7 | 91/9 |
| 9 | nBuLi | 0 °C | ↑ | 72 | 19 | 79/21 |
| 10 | nBuLi | rt | ↑ | 79 | 12 | 87/13 |
| 11 | NaH | 0 °C | 30 min | 89 | 3 | 97/3 |
| 12 | NaH | rt | ↑ | 90 | 2 | 97/3 |
| 13 | tBuOK | 0 °C | ↑ | 85 | 10 | 89/11 |
| 14 | tBuOK | rt | 20 min | 82 | 8 | 91/9 |
| 15 | iPrMgBr | –78 °C | ↑ | 4 | 0 | 100/0 |
| 16 | iPrMgBr | 0 °C | ↑ | 27 | trace | 99/1 |
| 17 | iPrMgBr | rt | ↑ | 58 | 1 | 98/2 |
| 18 | iPrMgBr | rt | 4 h | 73 | 1 | 99/1 |
As a preliminary investigation, we first employed lithium bis(hexamethyldisilazide) (LHMDS) as a strong base for deprotonation of the HWE reagent, which is a commonly used strong base for the HWE reaction.11 At –78 °C, the HWE reaction was (Z)-selective (Table 2, entry 1), whereas the (E)-selective product was favored with increasing reaction temperature (Table 2, entries 1–4). This effect of the reaction temperature is consistent with Heathcock’s pioneering report9 and Davies’ report.8
Next, to confirm the cation effect on the Weinreb amide-type HWE reaction, we examined HMDS bases with other alkali metal cations (Li vs Na vs K), among which the sodium cation was conducive to the (E)-selectivity (Table 2, entries 2 and 3 vs 5 and 6 vs 7 and 8). This cation effect was also observed with other conjugated bases, including nBuLi, NaH, and potassium tert-butoxide (tBuOK) (Table 2, entries 9–14). As a divalent cation and a congener of sodium ion, we also evaluated magnesium(II) ion (Table 2, entries 15–18).13a As the reaction temperature increased, the yield of the reaction product increased. However, at a difference with alkali metal cations, the selectivity observed in the reactions with magnesium cation was independent of the reaction temperature. Thus, at low temperature, the Weinreb amide-type HWE reaction using isopropylmagnesium bromide (iPrMgBr) as a base gave a low yield of the elongated product, which increased upon increasing the temperature (Table 2, entries 15–18), but the (E)-5c product was completely favored regardless of temperature. Therefore, the effect of conjugated base is much less effective on (E)-selectivity than that of the corresponding cation and that of the reaction temperature (Table 2, entries 3 and 10 vs 6 and 12 vs 8 and 14). The considerable effect of the magnesium(II) cation on the (E)-selectivity can be explained in terms of the resonance structures of the metal cation–phosphonoenolate complex generated in the presence of a strong base, as shown in Figure 1.
Figure 1.

Resonance structures of metal cation–phosphonoenolate.
Four resonance forms can be drawn for the Weinreb amide-type phosphonoenolate, i.e., P=O enolate form, P+–O– enolate form, P=O ylene form, and P+–O– ylene form (Figure 1). P=O enolate form has been generally invoked to explain the generation of stable phosphonoenolates from phosphates possessing an electron-withdrawing group to eventually give (E)-olefins selectively. P=O enolate form and P=O ylene form would contribute to the stability of phosphonoenolates with monovalent alkali metal cations (M = Li, Na, and K). In contrast, P+–O– enolate form and P+–O– ylene form would contribute to the stability of the phosphonoenolate of the divalent magnesium cation. In general, the Coulomb attractive force is proportional to the product of two charges and inversely proportional to the square of the distance between two ions. Therefore, the magnesium(II) phosphonoenolate is more stable than the phosphonoenolates, which responded to the strength of electrostatic stabilization involving the six-membered ring. The origin of the (E)-selectivity of the HWE reaction is generally explained by a stable phosphonoenolate giving a stable intermediate to afford the corresponding (E)-olefin. Our proposal is consistent with this rationale and is supported by our experimental results, according to which the iPrMgBr-deprotonating HWE reaction is slower than the LHMDS- and nBuLi-deprotonating HWE reactions, whereas the iPrMgBr-deprotonating HWE reaction is more (E)-selective than the LHMDS- and nBuLi-deprotonating HWE reactions (Table 2, entries 1–3, and 9 and 10 vs 15–18).
Effect of Weak Base Conditions and Cation on the Yield and Selectivity of the Weinreb Amide-Type HWE Reaction
Next, we used Seidel’s conditions to investigate the Weinreb amide-type HWE reaction under weak base conditions. In their pioneering work on a HWE reaction using a weak base, Masamune, Roush, and co-workers reported in 1984 that the combination of a lithium cation and a tertiary amine was effective for the (E)-selective HWE reaction and suitable for base-sensitive substrates.12 Subsequently, Rathke revealed that the magnesium ion–mediated Masamune–Roush conditions were also effective.13 Thus, we investigated the Weinreb amide-type HWE reaction using weak bases under Masamune–Roush’s conditions,12 Rathke’s conditions,13 and Seidel’s conditions7 (Table 3).
Table 3. Weinreb Amide-Type HWE Reaction under Weak Base Conditions and Effect of Cation, Solvent, and Temperature.
| Yield (%) |
||||||||
|---|---|---|---|---|---|---|---|---|
| Entry | Lewis Acid | Base | Solvent | Temperature | Time | (E)-5c | (Z)-5c | E/Z |
| 1 | LiCl | DBU | THF | rt | 1.5 h | 78 | 12 | 87/13 |
| 2a | ↑ | ↑ | MeCN | ↑ | ↑ | 83 | 3 | 97/3 |
| 3 | ↑ | NEt3 | THF | ↑ | ↑ | 9 | 1 | 93/7 |
| 4 | ↑ | ↑ | MeCN | ↑ | ↑ | 47 | trace | >99/1 |
| 5 | ↑ | iPr2NEt | THF | ↑ | ↑ | 3 | trace | >99/1 |
| 6a | ↑ | ↑ | MeCN | ↑ | ↑ | 28 | trace | >99/1 |
| 7 | ↑ | NEt3 | THF | ↑ | 12 h | 47 | 9 | 83/17 |
| 8 | ↑ | ↑ | MeCN | ↑ | ↑ | 69 | 1 | 99/1 |
| 9 | ↑ | iPr2NEt | THF | ↑ | ↑ | 12 | 1 | >99/1 |
| 10 | ↑ | ↑ | MeCN | ↑ | ↑ | 66 | trace | >99/1 |
| 11 | MgBr2 | DBU | THF | 50 °C | 1.5 h | 38 | 2 | 95/5 |
| 12b | ↑ | NEt3 | ↑ | ↑ | ↑ | 28 | 1 | 96/4 |
| 13 | ↑ | iPr2NEt | ↑ | ↑ | ↑ | 26 | 2 | 95/5 |
Under the mentioned conditions and their modifications, 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU), triethylamine (NEt3), and N,N-diisopropylethylamine (iPr2NEt) are generally employed as the weak bases. Hence, we selected these three bases as the deprotonating source of the HWE reagent. In contrast to the case of strong base conditions, lithium cation was more effective for the (E)-selectivity (Table 3, entries 2, 4–6, and 8–10) than the magnesium cation (Table 3, entries 11–13). In addition, the yield of (E)-5c obtained under mild reaction conditions was lower than that obtained under strong base conditions. Under our conditions employing magnesium cation as the activating reagent (Table 3, entries 11–13), the (E)-selectivity was worse than under strong base conditions. These results might stem from the difference in the conjugated base anion. Deprotonation of the Weinreb amide-type HWE reagent with iPrMgBr afforded the magnesium phosphonoenolate accompanied by propane and the newly generated vacant coordination space of the magnesium atom. This vacant coordination space would be simultaneously occupied by tetrahydrofuran (THF) solvent, which is a much weaker coordinating ligand than the bromide anion (Br–). Therefore, the difference in the coordination ligands around the magnesium(II) cation could contribute to the corresponding difference in (E)-selectivity between strong base conditions and weak base conditions.
Phosphonoenolate Amount and Effect of Alkyl and Halogen Moieties in the Grignard Reagent
Next, we optimized the amount of iPrMgBr and Weinreb amide-type HWE reagent to increase the yield of (E)-5c while maintaining high (E)-selectivity (Table 4). When treated with 1.5 equiv of phosphonoenolate, 4c was almost consumed and the yield of (E)-5c was increased within 1.5 h. Further experiments revealed that the optimal amounts of Weinreb amide-type HWE reagent and iPrMgBr were 2.0 and 1.8 equiv, respectively.
Table 4. Screening of the Amount of Weinreb Amide-Type HWE Reagent and iPrMgBr.
| Yield (%) |
||||||
|---|---|---|---|---|---|---|
| Entry | X (equiv) | Y (equiv) | Time (h) | (E)-5c | (Z)-5c | rSM (%) |
| 1 | 1.2 | 1.1 | 4 | 73 | 1 | 8 |
| 2 | 1.6 | 1.5 | 1.5 | 79 | 2 | trace |
| 3 | 2.0 | 1.8 | ↑ | 84 | 3 | 0 |
| 4 | 2.4 | 2.2 | ↑ | 76 | trace | 0 |
To further improve the reaction outcome, we examined the effect of alkyl and halogen moieties in the Grignard reagent on the yield and (E)-selectivity (Table 5). Methylmagnesium bromide, which was employed by Davies,8 gave moderate yield and high (E)-selectivity (Table 5, entry 1). The alkyl moiety in alkyl magnesium bromides did not exert a remarkable effect on the reaction yield and (E)-selectivity (Table 5, entries 2, 6, 8, and 10). Conversely, the halogen anion (Cl–, Br–, and I–) had a considerable effect (Table 5, entries 2–4 and 10 and 11). These results suggest that the halogen ligand on the Grignard reagent was transferred to the corresponding phosphonoenolate via deprotonation with the coordinated magnesium cation, resulting in a Mg(II)–X (X = Cl, Br, and I) structure as the active species for the Weinreb amide-type HWE reaction.
Table 5. Effect of Alkyl and Halogen Moieties on the Grignard Reagent on the Yield and (E)-Selectivity.
| Yield (%) |
||||||
|---|---|---|---|---|---|---|
| Entry | Base | Temperature | Time (h) | (E)-5c | (Z)-5c | E/Z |
| 1 | MeMgBr | 0 °C | 5 | 70 | 1 | 99/1 |
| 2 | MeMgBr | rt | 1.5 | 82 | 2 | 98/2 |
| 3 | MeMgCl | rt | 1.5 | 89 | 2 | 98/2 |
| 4 | MeMgI | rt | 1.5 | 29 | trace | >99/1 |
| 5 | EtMgBr | 0 °C | 5 | 63 | trace | 97/3 |
| 6 | EtMgBr | rt | 1.5 | 83 | 1 | 99/1 |
| 7 | PhMgBr | 0 °C | 3.5 | 64 | trace | >99/1 |
| 8 | PhMgBr | rt | 1.5 | 82 | 2 | 98/2 |
| 9 | iPrMgBr | 0 °C | 5 | 63 | 1 | 98/2 |
| 10 | iPrMgBr | rt | 1.5 | 84 | 3 | 96/4 |
| 11 | iPrMgCl | rt | 1.5 | 94 | 1 | 99/1 |
| 12 | iPrMgCl·LiCl | rt | 1.5 | 90 | 2 | 98/2 |
Effect of Type and Amount of Solvent on the Yield and Selectivity of the Weinreb Amide-Type HWE Reaction
To investigate the effect of the type and amount of solvent on the Weinreb amide-type HWE reaction, we employed some representative solvents and three concentration conditions using iPrMgCl as the deprotonating reagent (Table 6).
Table 6. Effect of Type and Amount of Solvent.
| Yield (%) |
||||||
|---|---|---|---|---|---|---|
| Entry | Solvent | X (M) | Time (h) | (E)-5c | (Z)-5c | E/Z |
| 1 | THF | 0.03 | 1.5 | 94 | 1 | 99/1 |
| 2 | DME | ↑ | ↑ | 78 | trace | >99/1 |
| 3 | Et2O | ↑ | ↑ | 23 | 0 | 100/0 |
| 4 | MeCN | ↑ | ↑ | 15 | trace | >99/1 |
| 5 | toluene | ↑ | ↑ | 17 | 3 | 85/15 |
| 6a | THF | 0.03 | 1.5 | 90 | 2 | 98/2 |
| 7a | ↑ | 0.1 | 2.0 | 85 | 1 | 99/1 |
| 8a | ↑ | 0.3 | 5.0 | 87 | 1 | 98/2 |
1.0 mmol of 4c was used.
Among the three etheric solvents evaluated, i.e., THF, 1,2-dimethoxyethane (DME), and diethyl ether (Et2O), THF was the best solvent (Table 6, entries 1–3). Conversely, acetonitrile, which is also an aprotic solvent, gave a low yield (Table 6, entry 4). The low-polar solvent toluene, which is frequently employed in the Wittig reaction, also afforded the product in low yield and with moderate selectivity (Table 6, entry 5). This solvent effect suggests that the reactive species contains solvent molecules. Furthermore, the reaction required more time as the concentration was increased. These solvent and concentration effects indicate that the active species could form a dimer containing solvent molecules under high concentration conditions, as shown in Figure 2.
Figure 2.
Proposed structure of the active species and its dimer.
To the best of our knowledge, no report has described the isolation of a reactive phosphonoenolate species in the HWE reaction. As an example of indirect detection via the phosphorus-31 nuclear magnetic resonance (31P NMR) and infrared (IR) spectroscopy, Seyden-Penne and co-workers revealed in 1987 that a lithium phosphonoenolate forms a chelated structure and a dimer in solution under high concentrations conditions.14 Accordingly, the reaction concentration could affect the reaction rate owing to the equilibrium of the phosphonoenolate. Our experimental results support this assumption, which is also in accord with our proposed structure for the active species. According to our results, we selected the following as the optimal reaction conditions: 2.0 equiv of Weinreb amide-type HWE reagent and 1.8 equiv of iPrMgCl as elongating reagents, 0.03 M of THF as the reaction solvent, and room temperature as the reaction temperature.
Isolation of a Reactive Magnesium Phosphonoenolate and HWE Reaction of Isolated Magnesium Weinreb Amide-Type Phosphonoenolate
According to our results suggesting the high stability of the magnesium phosphonoenolate, we considered that it could be isolated. In fact, the magnesium phosphonoenolate was obtained as a white solid by concentrating a solution of the phosphonoenolate generated using iPrMgCl under argon atmosphere (Scheme 2). The absence of sharp signals in the proton (1H) NMR spectrum was indicative of the paramagnetic character of the isolated phosphonoenolate or that in the solution. Nevertheless, the presence of THF molecules in the phosphonoenolate solid could be ascertained. The phosphonoenolate could be also isolated from a toluene solution. In this case, the 1H NMR spectrum did not reveal the presence of toluene molecules in the phosphonoenolate structure. To get further information on the isolated phosphonoenolate, which the crystallization of both complexes is currently underway, we measured the IR spectrum of the isolated phosphonoenolates. The vibration frequency of the carbonyl group in 1 was 1666 cm–1, whereas the corresponding frequencies of isolated phosphonoenolates 7 and 8 were 1636 cm–1. On the other hand, the frequency of P=O vibration of 1 was 1257 cm–1 shifted to 1248 and 1249 cm–1 in 7 and 8 respectively, by the formation of phosphonoenolates. These decreasing shifts showed that the formation of phosphonoenolates weakened P=O bond,15 and it supports the proposed structure of the isolated phosphonoenolates and the stabilization of phosphonoenolate.
Scheme 2. Isolation of Magnesium Phosphonoenolates.

Using the isolated magnesium phosphonoenolates, we conducted the HWE reaction of 3-phenylpropanal, which afforded the corresponding (E)-olefin selectively without significant differences in the yield and selectivity compared with a control experiment (Scheme 3). The desolvated phosphonoenolate 8 isolated from toluene solution was more stable than the solvated phosphonoenolate 7 isolated from THF solution, since 7 became damp under touch with a spatula. In contrast, phosphonoenolate 8 could be stored at least for over a half year at room temperature in argon atmosphere and then used for the HWE reaction without any change in the yield and selectivity. To the best of our knowledge, this is the first report on the isolation of the phosphonoenolate intermediate and the application of the isolated phosphonoenolate to induce the HWE reaction. Similarly, the lithium phosphonoenolate could be isolated and used for the HWE reaction.16 In addition, not only the Weinreb amide-type phosphonoenolates but also ethyl ester-type phosphonoenolates were isolable and reactive.17 Therefore, this method for the isolation of phosphonoenolates and their application in the HWE reaction could be extended to various HWE reagents and applied to other systems such as solid-phase HWE reactions. Practically, we can use the solid phosphonoenolate as the additional amount of reagent at the time that the reaction is just proceeding, without increasing the volume of solvent.
Scheme 3. HWE Reaction of the Isolated Magnesium Phosphonoenolate.
Effect of the Phosphonate Ester Group in the Weinreb Amide-Type HWE Reagent
Next, we investigated the effect of the structure of the HWE reagent on the yield and selectivity of the Weinreb Amide-type HWE reaction (Table 7).
Table 7. Effect of the Phosphonate Ester Group on the Selectivity of the Weinreb Amide-Type HWE Reaction.
| Yield (%) |
|||||
|---|---|---|---|---|---|
| Entry | R1O | R2O | (E)-5c | (Z)-5c | E/Z |
| 1 | MeO | MeO | 91 | 3 | 97/3 |
| 2 | EtO | EtO | 94 | 1 | 99/1 |
| 3 | iPrO | iPrO | 41 | 1 | 98/2 |
| 4 | PhO | PhO | 46 | 45 | 50/50 |
| 5 | CF3CH2O | EtO | 83 | 5 | 95/5 |
| 6 | CF3CH2O | CF3CH2O | 17 | 70 | 19/81 |
Although dimethyl phosphonate has similar reactivity to diethyl phosphonate, the selectivity induced by the former was lower than that by the latter (Table 7, entry 1 vs 2). Diisopropyl phosphonate gave lower yield than diethyl phosphonate (Table 7, entry 2 vs 3). This can be attributed to the bulkiness of the phosphonate group increasing the activation energy. We also employed electron-withdrawing alkyl phosphonates. Representative (Z)-selective HWE reagents such as the Still–Gennari reagent3w and the Ando reagent3ag have a bis(2,2,2-trifluoroethyl) phosphonate ester moiety and diphenyl phosphonate ester moiety, respectively. It has long been known that the structure of the phosphonate ester moiety affects the selectivity of the HWE reaction; however, the effect of subjecting (Z)-selective HWE reagents to highly (E)-selective conditions is unknown. The Weinreb amide-type Ando reagent3aj gave no selective reaction product under our optimized conditions (Table 7, entry 4), and the Weinreb amide-type Still–Gennari reagent3al afforded selectively the (Z)-olefin. These results suggest that the Ando reagent is more affected by the cation effect than the Still–Gennari reagent. When ethyl (2,2,2-trifluoroethyl) phosphonate was subjected to the optimized reaction conditions, the (E)-olefin was selectively obtained, indicating that a (Z)-selective HWE reagent should possess two strong electron-withdrawing ester moieties. Consequently, the diethyl phosphonate moiety resulted in the most suitable Weinreb amide-type to obtain (E)-olefins under our optimized conditions.
Comparison among Wittig Reagents and HWE Reagents and among Ethyl Ester-Type Reagents and Weinreb Amide-Type Reagents
To compare Wittig reagents with HWE reagents and ethyl ester-type reagents with Weinreb amide-type reagents, we performed comparison experiments using each elongation reagent. Under the optimized conditions, the yield of the Weinreb amide-type HWE reaction was higher than that of the ethyl ester-type HWE reaction, and the selectivity was almost the same (Table 8, entry 1 vs 4). The difference in the yield might stem from the effect of the amide moiety, and the fact that the same selectivity was observed might be attributed to the effect of the magnesium cation and temperature. In the case of Weinreb amide-type reagents, the phosphonoenolate generated from the HWE reagent gave (E)-5c in higher yield than the Wittig reagent and the phosphonium salt (Table 8, entry 1 vs 2 and 3) because the Wittig reagent is more stable and less reactive than the phosphonoenolate generated from the HWE reagent. In general, the (E)-selectivity of the HWE reaction was higher than that of the Wittig reaction using Weinreb amide-type and ethyl ester-type reagents (Table 8, entries 1 vs 2 and 3 and 4 vs 5 and 6).
Table 8. Comparison among Wittig Reagents and HWE Reagents and among Ethyl Ester-Type Reagents and Weinreb Amide-Type Reagents.
Substrate Scope of Saturated Aliphatic Aldehydes for the iPrMgCl-Deprotonating Weinreb Amide-Type HWE Reaction
Using our optimized conditions, we investigated that the substrate scope of saturated aliphatic aldehydes for the iPrMgCl-deprotonating Weinreb amide-type HWE reaction (Table 9).
Table 9. Substrate Scope of Saturated Aliphatic Aldehydes in the Weinreb Amide-Type HWE Reaction.
Reaction (E)-products were highly volatile so that we could not get the accurate yield. Only (E)-selectivity was calculated from 1H NMR spectra of crude product.
(Z)-product was not detected in TLC monitoring. See also note a.
HWE reagent (3.0 equiv), iPrMgCl (2.7 equiv) were used and stirred for 12 h.
Yield of (E,E)-16k. (E,Z)-16k was also given in 3% yield. The ratio of E/Z is the ratio of (E,E)-16k/(E,Z)-16k. (Z,Z)-16k was not detected.
Reaction time was 20 min.
Reaction time was 12 h. In case that reaction time is 1.5 h, (E)-16r was 46% yield.
Purity: 91%.
Purity: 92%.
α-Primary aldehydes including middle-chain aliphatic aldehydes, β-branched aldehydes, a chiral aldehyde, and a dialdehyde gave (E)-olefins selectively (Table 9, entries 1, 2, and 6–11). Particularly, the dialdehyde enabled the bidirectional elongation to give the double-elongated (E,E)-olefin selectively. In this case, (Z,Z)-olefin was not detected and the result indicated that each elongation was highly (E)-selective. Not only α-primary aldehydes but also α-secondary and α-tertiary aldehydes gave the (E)-Weinreb amides in excellent yield with complete (E)-selectivity (Table 9, entries 3 and 4). Generally, in the case of aldehydes possessing an α-acidic proton, epimerization of the aldehydes or the elongation products and regioisomerization of products could occur. However, regioisomerization of the reaction product was not detected under the optimized conditions (Table 9, entry 12). Even employing α-epimerizable aldehydes, the corresponding (E)-olefins were obtained in good yield with good selectivity without epimerization (Table 9, entries 16 and 17). Other α-secondary aldehydes such as α-cycloalkyl aldehydes were also applicable, affording good yield and high selectivity without regioisomerization (Table 9, entries 13–15). Meanwhile, an α-carbocycle-possessing aldehyde also afforded the corresponding (E)-olefin in good yield with high selectivity without undergoing ring opening (Table 9, entry 18). Conversely, aldehydes containing a highly acidic proton did not give any elongation product (Table 9, entries 19 and 20), which was the only limitation in the substrate scope of this HWE reaction.
Substrate Scope of α,β-Unsaturated Aliphatic Aldehydes for the iPrMgCl-Deprotonating Weinreb Amide-Type HWE Reaction
Next, we expanded the substrate scope of the Weinreb amide-type HWE reaction to representative unsaturated aliphatic aldehydes (Table 10). Our optimized conditions were applicable to α,β-unsaturated aliphatic aldehydes, although longer reaction times (12 h) were required owing to their lower reactivity compared with saturated aliphatic aldehydes. In addition, an α-methyl substituent slowed down the reaction (Table 10, entries 1 vs 2), whereas an electron-withdrawing α-bromo substituent did not (Table 10, entry 5).18 Furthermore, not only α,β-unsaturated aliphatic aldehydes but also a propargyl aldehyde was applicable to this reaction (Table 10, entry 3). An α,β,γ,δ-unsaturated aliphatic aldehyde gave the elongated α,β,γ,δ,ε,ζ-unsaturated aliphatic olefin in good yield with high selectivity. This elongation result prompted us to evaluate the successive elongation process using the iPrMgCl-deprotonating Weinreb amide-type HWE reaction.
Table 10. Substrate Scope of Unsaturated Aliphatic Aldehydes in the iPrMgCl-Deprotonating Weinreb Amide-Type HWE Reaction.
THF (0.2 M), 21 h, 20 mmol scale.
Substrate Scope of Aromatic Aldehydes for the iPrMgCl-Deprotonating Weinreb Amide-Type HWE Reaction
We also expanded the substrate scope of the Weinreb amide-type HWE reaction to various aromatic aldehydes (Table 11). Similar to α,β-unsaturated aliphatic aldehydes, aromatic aldehydes needed longer reaction times than saturated aliphatic aldehydes. In the case of ortho-, meta-, and para-tolualdehydes, no substituent effect was observed, and their reactions gave the corresponding (E)-olefins in good yield (Table 11, entries 2–4). To examine the steric effect of substituents on the aromatic ring, 2,6-dimethylbenzaldehyde, which could suppress the rotation of the aromatic ring because of the two directional substituents, was subjected to the reaction conditions to afford the elongation product with a good yield and complete (E)-selectivity, albeit with higher reaction temperature and longer reaction time (Table 11, entry 5). Electron-withdrawing and electron-donating groups did not affect the reaction yield and selectivity (Table 11, entries 6, 7, and 9–13). The aldehyde possessing an acetyl group also gave the (E)-olefin stereoselectively while the acetyl group remained intact (Table 11, entry 14), indicating that the acyclic ketone moiety does not need protection under these reaction conditions. Aldehydes containing an acidic proton, i.e., those with a carboxyl group, a phenolic hydroxy group, a boronic acid group, an NH-free pyrrolyl group, and an NH-free indolyl group, required high temperature but gave the (E)-olefin in good yields and with complete (E)-selectivity in most cases (entries 15–17, 24, and 26). In addition, heterocyclic aldehydes such as pyridinyl, furyl, thiophenyl, and pyrrolyl aldehydes were applicable to this HWE reaction. However, only 2-pyridynecarbardehyde gave the corresponding olefin in low yield, which could be due to the directing pyridinyl nitrogen being closer to the reaction site than that of 3-pyridynecarbaldehyde and 4-pyridinecarbardehyde. Meanwhile, polycyclic aromatic aldehydes were also suitable substrates (Table 11, entries 27 and 28). 9-Anthracenecarbaldehyde needed higher reaction temperature and longer reaction time due to the steric hindrance of the two bidirectionally extended rings (Table 11, entry 28). As multireactive-site substrates, aromatic dialdehydes including ortho-, meta-, and para-phtalaldehydes were also applicable without producing the double-elongated (Z,Z)-olefins and (E,Z)-olefins (Table 11, entries 29–31). The monoelongated intermediates, in which only one of two formyl groups reacted and the other remained intact, also gave the (E)-olefins in moderate yields. Furthermore, a trialdehyde was also subjected to the reaction conditions to afford the triple-elongated product in a moderate yield. Even though the probability of obtaining an (E,E,Z)-trielongated olefin is three times higher than that of producing a (Z)-olefin from a monoaldehyde such as benzaldehyde, the trielongated compounds were only obtained as (E,E,E)-olefins. This result confirmed that our reaction conditions provided very high (E)-selectivity in the case of aromatic aldehydes.
Table 11. Substrate Scope of Aromatic Aldehydes in the iPrMgCl-Deprotonating Weinreb Amide-Type HWE Reaction.
Reflux, 6 h.
Reflux, 6 h.
1 (3.0 equiv), iPrMgCl (2.7 equiv), reflux, 6 h.
1 (3.0 equiv), iPrMgCl (2.7 equiv), reflux, 24 h.
1 (3.0 equiv), iPrMgCl (2.7 equiv), reflux, 4 h.
1 (3.0 equiv), iPrMgCl (2.7 equiv), reflux, 24 h.
Reflux, 6 h.
1 (3.0 equiv), iPrMgCl (2.7 equiv), reflux, 24 h.
Reflux, 6 h.
Yield of (E,E)-20ac. (E)-20ac that one of two formyl groups was reacted also given in a 23% yield. (Z)-20 is (Z,Z)-20ac and (E,Z)-20ac, and they were not detected. The ratio of E/Z is the ratio of (E,E)-20ac/other geometric isomers.
1 (4.0 equiv), iPrMgCl (3.6 equiv), reflux, 6 h.
Yield of (E,E)-20ad, ae and (Z,Z)-20ad, ae. The ratio of E/Z is the ratio of (E,E)-20ad, ae/(E,Z)-20ad, ae. Other geometric isomers and unilateral elongation products were not detected.
1 (6.0 equiv), iPrMgCl (5.4 equiv), reflux 4 h.
Yield of (E,E,E)-20af. The ratio of E/Z is the ratio of (E,E,E)-20af/other geometric isomers.
Other geometric isomers, unilateral elongation products, and other intermediates were not detected.
Application of the iPrMgCl-Deprotonating Weinreb Amide-Type HWE Reaction to Successive Elongation
The polyene structure is present in many natural products,19 pigments,20 and bioimaging and biosensing probes;21 therefore, the development of a synthetic methodology to polyene compounds is highly desired. Typically, ester-type HWE reagents are used for successive elongation (Scheme 4). The produced ester (B) requires reduction to the corresponding aldehyde for the subsequent elongation. However, the ester group is sometimes excessively reduced to the corresponding hydroxy group (from B to C). Therefore, successive elongation has been commonly performed using a redox process involving the HWE reaction, reduction to alcohol, and oxidation to aldehyde.22 To improve the synthetic efficiency, we addressed the successive elongation by taking advantage of the selective reduction of the Weinreb amide (D) to the corresponding aldehyde (A′) and the following our HWE reaction (from A′ to D′), which would eliminate a step in each elongation process.
Scheme 4. Comparison of the Successive Elongation Strategy between Ethyl Ester-Type HWE Reagent and Weinreb Amide-Type HWE Reagent.
The successive elongation of benzaldehyde was performed (Scheme 5). In this process, the Still–Gennari reagent was employed as a (Z)-selective Weinreb amide-type HWE reagent. The first processes were completely (E)- and (Z)-selective and afforded good yield. The second processes were highly selective and also gave the olefins in good yields. The minor stereoisomers were easily separable via silica gel chromatography by virtue of the structure of the α,β-unsaturated Weinreb amide. In this two processes, all stereoisomers of α,β,γ,δ-unsaturated Weinreb amide were synthesized selectively in high yields. As a representative substrate, (2E,4E)-18d was subjected to a third process to afford (2E,4E,6E)-18f. In successive elongation processes, all-trans-triene was obtained after five steps in 61% yield, enabling further elongation.
Scheme 5. Selective Synthesis of (2E,4E)-, (2Z,4E)-, (2E,4Z)-, (2Z,4Z)-Olefins and (2E,4E,6E)-Olefin via Successive Elongation.

As a second application of successive elongation, we conducted the synthesis of a polycyclopropane (Scheme 6).23 Some natural products, such as Jawsamycin (FR-900848)24 and U106305,25 contain a polycyclopropane structure. As a model substrate, we subjected the elongated unsaturated Weinreb amide (E)-20a to the cyclopropanation reaction. The reaction of (E)-20a with a sulfoxonium ylide gave cyclopropane trans-22, which was reduced to aldehyde trans-15r. This aldehyde was elongated again under our optimized conditions to give trans-(E)-16r. The obtained trans-(E)-16r was subjected to a second cyclopropanation reaction to afford a mixture of trans-syn-trans-23 and trans-anti-trans-23, in which two cyclopropane rings are directly linked.
Scheme 6. Synthesis of Biscyclopropane as a Model of Polycyclopropane Natural Products.

Application of the HWE Reaction to a Ketone and Weinreb Ketone Syntheses
Using our synthetic method to obtain α,β-unsaturated Weinreb amides from aldehydes via the HWE reaction, we applied the HWE reaction to a ketone and performed the Weinreb ketone syntheses of elongated products (Scheme 7).5b
Scheme 7. HWE Reaction of a Ketone and Weinreb Ketone Syntheses.
The representative cyclic ketone cyclohexanone (24) was subjected to our optimized conditions to afford elongated Weinreb amide 25 in high yield, demonstrating that our conditions are applicable to cyclic ketones. Next, the Weinreb ketone syntheses were performed. Using MeMgBr, elongated syn-16p and anti-16q were converted to methyl ketones syn-26 and anti-26, respectively, in high yields without epimerization or regioisomerization.
Conclusion
We have developed an iPrMgCl-deprotonating (E)-selective Weinreb amide-type HWE reaction. Using Nuzillard’s conditions, we observed low (E)-selectivity at low reaction temperatures, in contrast to Nuzillard’s results and in consistency with Davies’s argument. The magnesium cation proved to be conducive to the (E)-selectivity and reactivity under Weinreb amide-type HWE reaction conditions. The phosphonoenolate generated using iPrMgCl could be isolated as a THF-desolvated dimer, which was prepared in toluene solvent. The desolvated dimer was very stable at room temperature for at least half a year in argon atmosphere. The isolated phosphonoenolate could be also used for the HWE reaction to give the corresponding (E)-olefin selectively and in high yield. This is the first example of an isolated phosphonoenolate mediating the HWE reaction. In addition, our optimized conditions were applicable to various aliphatic saturated aldehydes, aliphatic α,β-unsaturated aldehydes, and aromatic aldehydes, demonstrating their robustness and scalability. Our methodology was successfully applied to the successive elongation process, HWE reaction of a cyclic ketone, and Weinreb ketone syntheses, enabling the synthesis of polyene compounds and their derivatives. The crystallization of the phosphonoenolate, DFT calculation study of the reactive species, and experimental mechanistic study of this reaction are currently in progress and will be reported in the near future.
Experimental Section
General Methods
Melting points are recorded on a Yanaco MP-S3. 1H, 13C, 31P and 19F NMR spectra were recorded on a JEOL JNM-ECA500II or a Bruker Biospin AVANCE 400 M with chloroform (in chloroform-d), with benzene (in benzene-d6), with acetone (in acetone-d6) or with dimethyl sulfoxide (in dimethyl sulfoxide-d6) as internal standard. 31P NMR spectra were recorded with triphenyl phosphine as the internal standard and 19F NMR was recorded with trifluoromethylbenzene or fluorobenzene as the internal standard. Structural assignments were made with additional information from gHMQC and gHMBC experiments. IR spectra were recorded on a Horiba FT-300 (FT-IR) or Jasco FT/IR-4600 (ATR-IR). Absorbance frequencies are recorded in reciprocal centimeters (cm–1). High resolution mass spectra (HRMS) were obtained from a Bruker Daltonics micro TOF focus. Ionization was achieved by ESI, modes of ionization, calculated, and found mass are given. Optical rotations were determined using a Jasco P-1020. All reactions were carried out under argon atmosphere in dried glassware.
Experimental Procedures and Physical Data of Compounds
General Procedure of iPrMgCl-Deprotonating Weinreb Amide-Type Horner–Wadsworth–Emmons Reaction
To a solution of phosphate 1 (2.0 equiv: 95.7 mg, 0.400 mmol) in THF (4.7 mL), a 2.0 M solution of isopropylmagnesium chloride in THF (1.8 equiv: 0.18 mL, 0.360 mmol) was added at −78 °C. After the reaction mixture was stirred at −78 °C for 30 min, a solution of an aldehyde (1.0 equiv: 0.200 mmol) in THF (2.0 mL) was added at temperature (room temperature or reflux), and the reaction mixture was stirred for Time. To the reaction mixture, saturated aqueous ammonium chloride was added at 0 °C, and the mixture was extracted with ethyl acetate, and the organic layer was dried over sodium sulfate. After filtration of the mixture and concentration of the solvent, the crude mixture was purified by thin layer chromatography on silica to afford alkene.
Substrate Scope of Saturated Aliphatic Aldehyde
(2E)-N-Methoxy-N-methylbut-2-enamide [(E)-16a]
Rf = 0.55 (silica gel, hexane/ethyl acetate = 2/1); FT-IR (neat) νmax: 2970, 2939, 1666, 1635, 1450, 1412, 1381, 1180, 1011, 964 cm–1; 1H NMR (500 MHz, CDCl3, δ): 6.99 (dq, J = 15.5, 7.0 Hz, 1H, H-3), 6.49–6.37 (m, 1H, H-2), 3.71 (s, 3H, OMe), 3.24 (s, 3H, NMe), 1.92 (dd, J = 7.0, 1.0 Hz, 3H, H-4); 13C{1H} NMR (125 MHz, CDCl3): δ166.9 (C-1), 142.8 (C-3), 120.1 (C-2), 61.6 (OMe), 32.2 (NMe), 18.2 (C-4); HRMS calcd for C6H11NO2Na [M + Na]+ 152.0682; found, 152.0685.
(2E)-N-Methoxy-N-methylpent-2-enamide ((E)-16b)
Rf = 0.36 (silica gel, hexane/ethyl acetate = 2/1); FT-IR (neat) νmax: 2970, 2939, 1666, 1635, 1458, 1412, 1381, 1180, 995 cm–1; 1H NMR (500 MHz, CDCl3, δ): 7.03 (dt, J = 15.5, 6.5 Hz, 1H, H-3), 6.39 (dt, J = 15.5, 1.5 Hz, 1H, H-2), 3.71 (s, 3H, OMe), 3.24 (s, 3H, NMe), 2.32–2.22 (m, 2H, H-4), 1.09 (t, J = 7.5 Hz, 3H, H-5); 13C{1H} NMR (125 MHz, CDCl3): δ 167.1 (C-1), 149.2 (C-3), 117.7 (C-2), 61.6 (OMe), 32.3 (NMe), 25.5 (C-4), 12.5 (C-5); HRMS calcd for C7H13NO2Na [M + Na]+ 166.0838; found, 166.0835.
(2E)-N-Methoxy-N,4-dimethylpent-2-enamide ((E)-16c)
Rf = 0.44 (silica gel, hexane/ethyl acetate = 2/1); FT-IR (neat) νmax: 2962, 2870, 1666, 1635, 1466, 1412, 1381, 1180, 1003, 957 cm–1; 1H NMR (500 MHz, CDCl3, δ): 6.96 (dd, J = 15.5, 6.5 Hz, 1H, H-3), 6.34 (dd, J = 15.5, 1.5 Hz, 1H, H-2), 3.71 (s, 3H, OMe), 3.24 (s, 3H, NMe), 2.50 (qqdd, J = 7.0, 7.0, 6.5, 1.5 Hz, 1H, H-4), 1.08 (d, J = 7.0 Hz, 6H, 4-Me, H-5); 13C{1H} NMR (125 MHz, CDCl3): δ 167.2 (C-1), 154.0 (C-3), 115.8 (C-2), 61.5 (OMe), 32.3 (NMe), 31.1 (C-4), 21.4 (4-Me, C-5); HRMS calcd for C8H15NO2Na [M + Na]+ 180.0995; found, 180.0991.
(2E)-N-Methoxy-N,4,4-trimethylpent-2-enamide ((E)-16d)
Rf = 0.52 (silica gel, hexane/ethyl acetate = 2/1); FT-IR (neat) νmax: 2962, 2908, 2870, 1666, 1628, 1466, 1412, 1381, 1180, 1003 cm–1; 1H NMR (500 MHz, CDCl3, δ): 7.00 (d, J = 16.0 Hz, 1H, H-3), 6.30 (d, J = 16.0 Hz, 1H, H-2), 3.71 (s, 3H, OMe), 3.25 (s, 3H, NMe), 1.10 (s, 9H, 4-Me, H-5); 13C{1H} NMR (125 MHz, CDCl3): δ 167.4 (C-1), 157.7 (C-3), 113.7 (C-2), 61.6 (OMe), 33.7 (C-4), 32.4 (NMe), 28.8 (4-Me, C-5); HRMS calcd for C18H34N2O4Na [2 M + Na]+ 365.2411; found, 365.2403.
(2E)-N-Methoxy-N-methyl-5-phenylpent-2-enamide ((E)-5c, (E)-16e)
Rf = 0.37 (silica gel, hexane/ethyl acetate = 2/1); FT-IR (neat) νmax: 2931, 1658, 1635, 1450, 1419, 1381, 987, 702 cm–1; 1H NMR (500 MHz, CDCl3, δ): 7.33–7.24 (m, 2H, Ar), 7.23–7.15 (m, 3H, Ar), 7.01 (dt, J = 15.5, 7.0 Hz, 1H, H-3), 6.39 (d, J = 15.5 Hz, 1H, H-2), 3.63 (s, 3H, OMe), 3.23 (s, 3H, NMe), 2.80 (t, J = 7.5 Hz, 2H, H-5), 2.61–2.57 (m, 2H, H-4); 13C{1H} NMR (125 MHz, CDCl3): δ 166.8 (C-1), 146.5 (C-3), 141.0 (Ar), 128.384 (Ar), 126.0 (Ar), 119.3 (C-2), 61.6 (OMe), 34.5 (C-5), 34.2 (C-4), 32.3 (NMe); HRMS calcd for C26H34N2O4Na [2 M + Na]+ 461.2411; found, 461.2391.
(2Z)-N-Methoxy-N-methyl-5-phenylpent-2-enamide ((Z)-5c, (Z)-16e)
Rf = 0.56 (silica gel, hexane/ethyl acetate = 2/1); FT-IR (neat) νmax: 2931, 1658, 1450, 1435, 1350, 1003, 702 cm–1; 1H NMR (500 MHz, CDCl3, δ): 7.31–7.25 (m, 2H, Ar), 7.24–7.20 (m, 2H, Ar), 7.20–7.15 (m, 1H, Ar), 6.26 (brd, J = 11.5 Hz, 1H, H-2), 6.13 (dt, J = 11.5, 7.5 Hz, 1H, H-3), 3.61 (s, 3H, OMe), 3.20 (s, 3H, NMe), 2.97 (brdt, J = 7.5, 7.5 Hz, 2H, H-4), 2.78 (t, J = 7.5 Hz, 2H, H-5); 13C{1H} NMR (125 MHz, CDCl3): δ 167.2 (C-1), 146.1 (C-3), 141.3 (Ar), 128.5 (Ar), 128.2 (Ar), 125.8 (Ar), 118.6 (C-2), 61.4 (OMe), 35.2 (C-5), 31.8 (NMe), 30.4 (C-4); HRMS calcd for C26H34N2O4Na [2 M + Na]+ 461.2411; found, 461.2394.
(2E)-N-Methoxy-N-methylhept-2-enamide ((E)-16f)
Rf = 0.44 (silica gel, hexane/ethyl acetate = 2/1); FT-IR (neat) νmax: 2954, 2931, 2870, 1666, 1635, 1466, 1412, 1381, 995 cm–1; 1H NMR (500 MHz, CDCl3, δ): 6.98 (dt, J = 15.5, 7.0 Hz, 1H, H-3), 6.39 (dt, J = 15.5, 1.0 Hz, 1H, H-2), 3.70 (s, 3H, OMe), 3.24 (s, 3H, NMe), 2.24 (tdd, J = 7.5, 7.0, 1.0 Hz, 2H, H-4), 1.51–1.41 (m, 2H, H-5), 1.36 (tq, J = 7.5, 7.0 Hz, 2H, H-6), 0.91 (t, J = 7.0 Hz, 3H, H-7); 13C{1H} NMR (125 MHz, CDCl3): δ 167.1 (C-1), 147.9 (C-3), 118.6 (C-2), 61.6 (OMe), 32.3 (NMe), 32.2 (C-4), 30.4 (C-5), 22.2 (C-6), 13.8 (C-7); HRMS calcd for C9H17NO2Na [M + Na]+ 194.1151; found, 194.1156.
(2E)-N-Methoxy-N-methylnon-2-enamide ((E)-5a, (E)-16g)
Rf = 0.43 (silica gel, hexane/ethyl acetate = 2/1); FT-IR (neat) νmax: 2931, 2854, 1666, 1635, 1466, 1412, 1381, 995 cm–1; 1H NMR (500 MHz, CDCl3, δ): 6.98 (dt, J = 15.5, 7.0 Hz, 1H, H-3), 6.39 (dt, J = 15.5, 1.0 Hz, 1H, H-2), 3.70 (s, 3H, OMe), 3.24 (s, 3H, NMe), 2.23 (dtd, J = 7.0, 6.5, 1.0 Hz, 2H, H-4), 1.47 (tt, J = 7.5, 6.5 Hz, 2H, H-5), 1.38–1.16 (m, 6H, H-6, H-7, H-8), 0.88 (t, J = 7.0 Hz, 3H, H-9); 13C{1H} NMR (125 MHz, CDCl3): δ 167.1 (C-1), 148.0 (C-3), 118.6 (C-2), 61.6 (OMe), 32.5 (C-4), 32.3 (NMe), 31.6 (C-7), 28.8 (C-6), 28.2 (C-5), 22.5 (C-8), 14.0 (C-9); HRMS calcd for C11H21NO2Na [M + Na]+ 222.1465; found, 222.1473.
(2Z)-N-Methoxy-N-methylnon-2-enamide ((Z)-5a, (Z)-16g)
Rf = 0.62 (silica gel, hexane/ethyl acetate = 2/1); FT-IR (neat) νmax: 2954, 2924, 2854, 1658, 1458, 1435, 1342, 1003 cm–1; 1H NMR (500 MHz, CDCl3, δ): 6.23 (brd, J = 11.5 Hz, 1H, H-2), 6.12 (dt, J = 11.5, 7.5 Hz, 1H, H-3), 3.68 (s, 3H, OMe), 3.21 (s, 3H, NMe), 2.62 (dt, J = 7.5, 7.0 Hz, 2H, H-4), 1.43 (tt, J = 7.5, 7.0 Hz, 2H, H-5), 1.38–1.22 (m, 6H, H-6, H-7, H-8), 0.88 (t, J = 7.0 Hz, 3H, H-9); 13C{1H} NMR (125 MHz, CDCl3): δ 167.6 (C-1), 147.8 (C-3), 117.9 (C-2), 61.4 (OMe), 32.0 (NMe), 31.7 (C-7), 29.3 (C-5), 29.1 (C-4), 29.0 (C-6), 22.6 (C-8), 14.0 (C-9); HRMS calcd for C11H21NO2Na [M + Na]+ 222.1465; found, 222.1464.
(2E)-N-Methoxy-N-methyldec-2-enamide ((E)-16h)
Rf = 0.53 (silica gel, hexane/ethyl acetate = 2/1); FT-IR (neat) νmax: 2931, 2854, 1666, 1635, 1466, 1412, 1381, 1180, 987 cm–1; 1H NMR (500 MHz, CDCl3, δ): 6.98 (dt, J = 15.5, 7.0 Hz, 1H, H-3), 6.39 (dt, J = 15.5, 1.0 Hz, 1H, H-2), 3.70 (s, 3H, OMe), 3.24 (s, 3H, NMe), 2.23 (dtd, J = 7.0, 6.5, 1.0 Hz, 2H, H-4), 1.47 (tt, J = 7.5, 6.5 Hz, 2H, H-5), 1.37–1.17 (m, 8H, H-6, H-7, H-8, H-9), 0.88 (t, J = 7.0 Hz, 3H, H-10); 13C{1H} NMR (125 MHz, CDCl3): δ 167.0 (C-1), 148.0 (C-3), 118.5 (C-2), 61.6 (OMe), 32.4 (C-4), 32.3 (NMe), 31.7 (C-8), 29.1 (C-7), 29.0 (C-6), 28.2 (C-5), 22.6 (C-9), 14.0 (C-10); HRMS calcd for C24H46N2O4Na [2 M + Na]+ 449.3350; found, 449.3346.
(2Z)-N-Methoxy-N-methyldec-2-enamide ((Z)-16h)
Rf = 0.71 (silica gel, hexane/ethyl acetate = 2/1); FT-IR (neat) νmax: 2924, 2854, 1658, 1458, 1435, 1342, 1180, 1003 cm–1; 1H NMR (500 MHz, CDCl3, δ): 6.23 (brd, J = 11.5 Hz, 1H, H-2), 6.12 (dt, J = 11.5, 7.0 Hz, 1H, H-3), 3.68 (s, 3H, OMe), 3.22 (s, 3H, NMe), 2.62 (dt, J = 7.0, 7.0 Hz, 2H, H-4), 1.43 (tt, J = 7.5, 7.0 Hz, 2H, H-5), 1.38–1.19 (m, 8H, H-6, H-7, H-8, H-9), 0.87 (t, J = 7.0 Hz, 3H, H-10); 13C{1H} NMR (125 MHz, CDCl3): δ 167.6 (C-1), 147.8 (C-3), 117.9 (C-2), 61.4 (OMe), 31.9 (NMe), 31.8 (C-8), 29.308 (C-5, C-7), 29.13 (C-4), 29.09 (C-6), 22.6 (C-9), 14.1 (C-10); HRMS calcd for C24H46N2O4Na [2 M + Na]+ 449.3350; found, 449.3353.
(2E)-N-Methoxy-N,5-dimethylhex-2-enamide ((E)-16i)
Rf = 0.42 (silica gel, hexane/ethyl acetate = 2/1); FT-IR (neat) νmax: 2954, 1666, 1635, 1466, 1412, 1381, 995 cm–1; 1H NMR (500 MHz, CDCl3, δ): 6.96 (dt, J = 15.5, 7.5 Hz, 1H, H-3), 6.38 (d, J = 15.5 Hz, 1H, H-2), 3.70 (s, 3H, OMe), 3.24 (s, 3H, NMe), 2.17–2.08 (m, 2H, H-4), 1.77 (tqq, J = 7.5, 7.0, 7.0 Hz, 1H, H-5), 0.93 (d, J = 7.0 Hz, 6H, 5-Me, H-6); 13C{1H} NMR (125 MHz, CDCl3): δ 166.9 (C-1), 146.7 (C-3), 119.6 (C-2), 61.6 (OMe), 41.7 (C-4), 32.3 (NMe), 27.9 (C-5), 22.3 (5-Me, C-6); HRMS calcd for C18H34N2O4Na [2 M + Na]+ 365.2411; found, 365.2416.
(5S,2E)-N-Methoxy-N,5,9-trimethyldeca-2,8-dienamide ((E)-16j)
Rf = 0.26 (silica gel, hexane/ethyl acetate = 2/1); [α]D21 + 4.5 (c 1.00, CHCl3); FT-IR (neat) νmax: 2962, 2916, 1666, 1635, 1450, 1419, 1381, 995 cm–1; 1H NMR (500 MHz, CDCl3, δ): δ 6.96 (dt, J = 15.5, 7.5 Hz, 1H, H-3), 6.39 (d, J = 15.5 Hz, 1H, H-2), 5.12–5.04 (m, 1H, H-8), 3.70 (s, 3H, OMe), 3.25 (s, 3H, NMe), 2.30–2.20 (m, 1H, H-4), 2.14–1.89 (m, 3H, H-4, H-7), 1.69–1.58 (m, 1H, H-5), 1.68 (d, J = 1.0 Hz, 3H, H-10), 1.60 (s, 3H, 9-Me), 1.43–1.30 (m, 1H, H-6), 1.25–1.12 (m, 1H, H-6), 0.91 (d, J = 7.0 Hz, 3H, 5-Me); 13C{1H} NMR (125 MHz, CDCl3): δ 166.9 (C-1), 146.7 (C-3), 131.3 (C-9), 124.4 (C-8), 119.7 (C-2), 61.6 (OMe), 39.9 (C-4), 36.6 (C-6), 32.3 (NMe), 32.2 (C-5), 25.7 (C-10), 25.5 (C-7), 19.5 (5-Me), 17.6 (9-Me); HRMS calcd for C28H50N2O4Na [2 M + Na]+ 501.3663; found, 501.3671.
(5S,2Z)-N-Methoxy-N,5,9-trimethyldeca-2,8-dienamide ((Z)-16j)
Rf = 0.47 (silica gel, hexane/ethyl acetate = 2/1); [α]D23 + 12.9 (c 1.00, CHCl3); FT-IR (neat) νmax: 2962, 2916, 1658, 1442, 1342, 1003 cm–1; 1H NMR (500 MHz, CDCl3, δ): 6.28 (brd, J = 11.5 Hz, 1H, H-2), 6.13 (dt, J = 11.5, 7.0 Hz, 1H, H-3), 5.12–5.05 (m, 1H, H-8), 3.68 (s, 3H, OMe), 3.21 (s, 3H, NMe), 2.68–2.47 (m, 2H, H-4), 2.08–1.90 (m, 2H, H-7), 1.68 (s, 3H, H-10), 1.64–1.54 (m, 1H, H-5), 1.60 (s, 3H, 9-Me), 1.43–1.33 (m, 1H, H-6), 1.26–1.14 (m, 1H, H-6), 0.92 (d, J = 7.0 Hz, 3H, 5-Me); 13C{1H} NMR (125 MHz, CDCl3): δ 167.6 (C-1), 146.7 (C-3), 131.1 (C-9), 124.7 (C-8), 118.7 (C-2), 61.4 (OMe), 36.7 (C-6), 36.0 (C-4), 32.9 (C-5), 31.9 (NMe), 25.7 (C-10), 25.5 (C-7), 19.5 (5-Me), 17.6 (9-Me); HRMS calcd for C28H50N2O4Na [2 M + Na]+ 501.3663; found, 501.3645.
(2E,14E)-N1,N16-Dimethoxy-N1,N16-dimethylhexadeca-2,14-dienediamide ((E,E)-16k)
Rf = 0.20 (silica gel, hexane/ethyl acetate = 1/1); FT-IR (neat) νmax: 2924, 2854, 1666, 1635, 1466, 1442, 1381, 995 cm–1; 1H NMR (500 MHz, CDCl3, δ): 6.98 (dt, J = 15.5, 7.5 Hz, 2H, H-3, H-14), 6.39 (d, J = 15.5 Hz, 2H, H-2, H-15), 3.70 (s, 6H, OMe), 3.24 (s, 6H, NMe), 2.23 (dt, J = 7.5, 7.0 Hz, 4H, H-4, H-13), 1.46 (tt, J = 7.5, 7.0 Hz, 4H, H-5, H-12), 1.37–1.18 (m, 12H, H-6, H-7, H-8, H-9, H-10, H-11); 13C{1H} NMR (125 MHz, CDCl3): δ 167.1 (C-1, C-16), 147.9 (C-3, C-14), 118.5 (C-2, C-15), 61.6 (OMe), 32.5 (C-4, C-13), 32.3 (NMe), 29.5 (C-6 or C-7 or C-8 or C-9 or C-10 or C-11), 29.3 (C-6 or C-7 or C-8 or C-9 or C-10 or C-11), 29.1 (C-6 or C-7 or C-8 or C-9 or C-10 or C-11), 28.3 (C-5, C-12); HRMS calcd for C20H36N2O4Na [M + Na]+ 391.2567; found, 391.2565.
(2E,14Z)-N1,N16-Dimethoxy-N1,N16-dimethylhexadeca-2,14-dienediamide ((E,Z)-16k)
Rf = 0.30 (silica gel, hexane/ethyl acetate = 1/1); ATR-IR νmax: 2927, 2854, 1664, 1634, 1464, 1441, 1000 cm–1; 1H NMR (500 MHz, CDCl3, δ): 6.98 (dt, J = 15.5, 7.0 Hz, 1H, H-3), 6.39 (d, J = 15.5 Hz, 1H, H-2), 6.23 (brd, J = 12.0 Hz, 1H, H-15), 6.12 (dt, J = 12.0, 7.0 Hz, 1H, H-14), 3.70 (s, 3H, 1NOMe), 3.68 (s, 3H, 16NOMe), 3.24 (s, 3H, 1NMe), 3.21 (s, 3H, 16NMe), 2.61 (td, J = 7.5, 7.0 Hz, 2H, H-13), 2.23 (td, J = 7.5, 7.0 Hz, 2H, H-4), 1.51–1.38 (m, 4H, H-5, H-12), 1.38–1.19 (m, 12H, H-6, H-7, H-8, H-9, H-10, H-11); 13C{1H} NMR (125 MHz, CDCl3): δ 167.5 (C-16), 167.1 (C-1), 148.0 (C-3), 147.8 (C-14), 118.6 (C-2), 117.9 (C-15), 61.6 (1NOMe), 61.4 (16NOMe), 32.5 (C-4), 32.3 (1NMe), 32.0 (16NMe), 29.52 (C-6 or C-7 or C-8 or C-9 or C-10 or C-11), 29.49 (C-6 or C-7 or C-8 or C-9 or C-10 or C-11), 29.41 (C-6 or C-7 or C-8 or C-9 or C-10 or C-11), 29.37 (C-6 or C-7 or C-8 or C-9 or C-10 or C-11), 29.33 (C-6 or C-7 or C-8 or C-9 or C-10 or C-11), 29.28 (C-6 or C-7 or C-8 or C-9 or C-10 or C-11), 29.2 (C-13), 29.1 (C-12), 28.3 (C-5); HRMS calcd for C20H36N2O4Na [M + Na]+ 391.2567; found, 391.2575.
(2E)-N-Methoxy-N-methyl-4,4-diphenylbut-2-enamide ((E)-16l)
Rf = 0.42 (silica gel, hexane/ethyl acetate = 2/1); mp: 83.9 °C; ATR-IR νmax: 1656, 1615, 1494, 1452, 1422, 1387, 995, 707 cm–1; 1H NMR (500 MHz, CDCl3, δ): 7.43 (dd, J = 15.5, 7.5 Hz, 1H, H-3), 7.35–7.26 (m, 4H, Ar), 7.27–7.16 (m, 6H, Ar), 6.34 (d, J = 15.5 Hz, 1H, H-2), 4.91 (d, J = 7.5 Hz, 1H, H-4), 3.61 (s, 3H, OMe), 3.23 (s, 3H, NMe); 13C{1H} NMR (125 MHz, CDCl3): δ 166.6 (C-1), 148.3 (C-3), 142.1 (Ar), 128.545 (Ar), 126.7 (Ar), 120.3 (C-2), 61.7 (OMe), 53.6 (C-4), 32.4 (NMe); HRMS calcd for C18H19NO2Na [M + Na]+ 304.1308; found, 304.1308.
(2Z)-N-Methoxy-N-methyl-4,4-diphenylbut-2-enamide ((Z)-16l)
Rf = 0.61 (silica gel, hexane/ethyl acetate = 2/1); ATR-IR νmax: 1653, 1494, 1449, 1393, 1353, 1000, 704 cm–1; 1H NMR (500 MHz, CDCl3, δ): 7.34–7.21 (m, 8H, Ar), 7.25–7.16 (m, 2H, Ar), 6.57 (dd, J = 11.0, 10.5 Hz, 1H, H-3), 6.42 (brd, J = 11.0 Hz, 1H, H-2), 6.23 (brd, J = 10.5 Hz, 1H, H-4), 3.65 (s, 3H, OMe), 3.22 (s, 3H, NMe); 13C{1H} NMR (125 MHz, CDCl3): δ 166.9 (C-1), 147.3 (C-3), 143.4 (Ar), 128.5 (Ar), 128.4 (Ar), 126.4 (Ar), 117.6 (C-2), 61.6 (OMe), 48.0 (C-4), 32.0 (NMe); HRMS calcd for C18H19NO2Na [M + Na]+ 304.1308; found, 304.1311.
(2E)-N-Methoxy-N-methyl-3-cyclopropylprop-2-enamide ((E)-16m)
Rf = 0.31 (silica gel, hexane/ethyl acetate = 2/1); FT-IR (neat) νmax: 3008, 2962, 2939, 1658, 1628, 1466, 1427, 1389, 1180, 1011, 980, 957, 941 cm–1; 1H NMR (500 MHz, CDCl3, δ): 6.50 (d, J = 15.5 Hz, 1H, H-2), 6.42 (dd, J = 15.5, 10.0 Hz, 1H, H-3), 3.71 (s, 3H, OMe), 3.23 (s, 3H, NMe), 1.67–1.53 (m, 1H, H-1′), 0.98–0.85 (m, 2H, H-2′, H-3′), 0.72–0.57 (m, 2H, H-2′, H-3′); 13C{1H} NMR (125 MHz, CDCl3): δ 167.1 (C-1), 152.6 (C-3), 115.6 (C-2), 61.6 (OMe), 32.3 (NMe), 14.7 (C-1′), 8.4 (C-2′, C-3′); HRMS calcd for C8H13NO2Na [M + Na]+ 178.0838; found, 178.0835.
(2Z)-N-Methoxy-N-methyl-3-cyclopropylprop-2-enamide ((Z)-16m)
Rf = 0.46 (silica gel, hexane/ethyl acetate = 2/1); ATR-IR νmax: 3005, 2937, 1654, 1623, 1463, 1445, 1353, 1179, 1002, 948, 926, 815 cm−1; 1H NMR (500 MHz, CDCl3, δ): 6.19 (d, J = 11.0 Hz, 1H, H-2), 5.38 (dd, J = 11.5, 11.0 Hz, 1H, H-3), 3.69 (s, 3H, OMe), 3.24 (s, 3H, NMe), 3.01–2.85 (m, 1H, H-1′), 1.02–0.90 (m, 2H, H-2′, H-3′), 0.58–0.46 (m, 2H, H-2′, H-3′); 13C{1H} NMR (125 MHz, CDCl3): δ 168.0 (C-1), 153.0 (C-3), 115.1 (C-2), 61.5 (OMe), 32.1 (NMe), 11.8 (C-1′), 8.8 (C-2′, C-3′); HRMS calcd for C8H13NO2Na [M + Na]+ 178.0838; found, 178.0831.
(2E)-N-Methoxy-N-methyl-3-cyclopentylprop-2-enamide ((E)-16n)
Rf = 0.38 (silica gel, hexane/ethyl acetate = 2/1); FT-IR (neat) νmax: 2954, 2870, 1658, 1628, 1450, 1419, 1381, 995 cm–1; 1H NMR (500 MHz, CDCl3, δ): 6.96 (dd, J = 15.0, 8.0 Hz, 1H, H-3), 6.37 (d, J = 15.0 Hz, 1H, H-2), 3.70 (s, 3H, OMe), 3.24 (s, 3H, NMe), 2.64 (ddddd, J = 8.5, 8.0, 8.0, 8.0, 8.0 Hz, 1H, H-1′), 1.92–1.78 (m, 2H, H-2′, H-5′), 1.77–1.52 (m, 4H, H-3′, H-4′), 1.52–1.35 (m, 2H, H-2′, H-5′); 13C{1H} NMR (125 MHz, CDCl3): δ 167.3 (C-1), 152.1 (C-3), 116.7 (C-2), 61.6 (OMe), 43.1 (C-1′), 32.6 (C-2′, C-5′), 32.4 (NMe), 25.3 (C-3′, C-4′); HRMS calcd for C10H17NO2Na [M + Na]+ 206.1151; found, 206.1150.
(2Z)-N-Methoxy-N-methyl-3-cyclopentylprop-2-enamide ((Z)-16n)
Rf = 0.58 (silica gel, hexane/ethyl acetate = 2/1); ATR-IR νmax: 2954, 2868, 1660, 1633, 1433, 1347, 1001 cm–1; 1H NMR (500 MHz, CDCl3, δ): 6.16 (brd, J = 11.0 Hz, 1H, H-2), 6.01 (dd, J = 11.0, 10.5 Hz, 1H, H-3), 3.72–3.52 (m, 1H, H-1′), 3.68 (s, 3H, OMe), 3.21 (s, 3H, NMe), 1.98–1.86 (m, 2H, H-2′, H-5′), 1.77–1.53 (m, 4H, H-3′, H-4′), 1.35–1.18 (m, 2H, H-2′, H-5′); 13C{1H} NMR (125 MHz, CDCl3): δ 167.7 (C-1), 152.3 (C-3), 116.5 (C-2), 61.4 (OMe), 39.3 (C-1′), 33.6 (C-2′, C-5′), 32.0 (NMe), 25.6 (C-3′, C-4′); HRMS calcd for C10H17NO2Na [M + Na]+ 206.1151; found, 206.1148.
(2E)-N-Methoxy-N-methyl-3-cyclohexylprop-2-enamide ((E)-16o)
Rf = 0.44 (silica gel, hexane/ethyl acetate = 2/1); FT-IR (neat) νmax: 2924, 2854, 1666, 1635, 1450, 1412, 1381, 1180, 1003, 987, 964 cm–1; 1H NMR (500 MHz, CDCl3, δ): 6.93 (dd, J = 15.5, 6.5 Hz, 1H, H-3), 6.34 (d, J = 15.5 Hz, 1H, H-2), 3.70 (s, 3H, OMe), 3.24 (s, 3H, NMe), 2.23–2.12 (m, 1H, H-1′), 1.83–1.70 (m, 4H, H-2′, H-3′, H-5′, H-6′), 1.72–1.63 (m, 1H, H-4′), 1.37–1.23 (m, 2H, H-2′, H-6′), 1.25–1.10 (m, 3H, H-3′, H-4′, H-5′); 13C{1H} NMR (125 MHz, CDCl3): δ 167.3 (C-1), 152.9 (C-3), 116.1 (C-2), 61.6 (OMe), 40.7 (C-1′), 32.3 (NMe), 31.9 (C-2′, C-6′), 25.9 (C-4′), 25.7 (C-3′, C-5′); HRMS calcd for C22H38N2O4Na [2 M + Na]+ 417.2724; found, 417.2742.
(2Z)-N-Methoxy-N-methyl-3-cyclohexylprop-2-enamide ((Z)-16o)
Rf = 0.70 (silica gel, hexane/ethyl acetate = 2/1); FT-IR (neat) νmax: 2924, 2854, 1658, 1442, 1342, 1003 cm–1; 1H NMR (500 MHz, CDCl3, δ): 6.14 (brd, J = 11.0 Hz, 1H, H-2), 5.93 (dd, J = 11.0, 10.5 Hz, 1H, H-3), 3.68 (s, 3H, OMe), 3.35–3.15 (m, 1H, H-1′), 3.22 (s, 3H, NMe), 1.80–1.60 (m, 5H, H-2′, H-3′, H-4′, H-5′, H-6′), 1.42–1.28 (m, 2H, H-2′, H-6′), 1.24–1.00 (m, 3H, H-4′, H-3′, H-5′); 13C{1H} NMR (125 MHz, CDCl3): δ 167.5 (C-1), 153.0 (C-3), 115.9 (C-2), 61.4 (OMe), 37.3 (C-1′), 32.5 (C-2′, C-6′), 32.0 (NMe), 26.0 (C-4′), 25.5 (C-3′, C-5′); HRMS calcd for C11H19NO2Na [M + Na]+ 220.1308; found, 220.1312.
(4RS,5SR,2E)-5-((tert-Butyldimethylsilyl)oxy)-N-methoxy-N,4-dimethyl-5-phenylpent-2-enamide ((E)-16p)
Rf = 0.53 (silica gel, hexane/ethyl acetate = 2/1); FT-IR (neat) νmax: 2954, 2931, 2893, 2854, 1666, 1635, 1466, 1412, 1381, 1257, 1088, 1065, 841, 779, 702 cm–1; 1H NMR (500 MHz, CDCl3, δ): 7.30–7.22 (m, 4H, Ar), 7.22–7.17 (m, 1H, Ar), 6.90 (dd, J = 15.5, 8.0 Hz, 1H, H-3), 6.21 (d, J = 15.5 Hz, 1H, H-2), 4.58 (d, J = 6.0 Hz, 1H, H-5), 3.54 (s, 3H, OMe), 3.20 (s, 3H, NMe), 2.62 (dqd, J = 8.0, 7.0, 6.0 Hz, 1H, H-4), 1.06 (d, J = 7.0 Hz, 3H, 4-Me), 0.88 (s, 9H, TBS), 0.03 (s, 3H, TBS), −0.21 (s, 3H, TBS); 13C{1H} NMR (125 MHz, CDCl3): δ 166.7 (C-1), 149.6 (C-3), 143.1 (Ar), 127.7 (Ar), 127.0 (Ar), 126.6 (Ar), 118.7 (C-2), 78.0 (C-5), 61.5 (OMe), 45.7 (C-4), 32.2 (NMe), 25.8 (TBS), 18.1 (TBS), 14.6 (4-Me), −4.7 (TBS), −5.1 (TBS); HRMS calcd for C20H33NO3SiNa [M + Na]+ 386.2122; found, 386.2103.
(4RS,5SR,2Z)-5-((tert-Butyldimethylsilyl)oxy)-N-methoxy-N,4-dimethyl-5-phenylpent-2-enamide ((Z)-16p)
Rf = 0.75 (silica gel, hexane/ethyl acetate = 2/1); FT-IR (neat) νmax: 2954, 2931, 2893, 2854, 1658, 1458, 1350, 1257, 1095, 1026, 1003, 856, 841, 779, 702 cm–1; 1H NMR (500 MHz, CDCl3, δ): 7.38–7.32 (m, 2H, Ar), 7.31–7.23 (m, 2H, Ar), 7.21–7.14 (m, 1H, Ar), 6.20 (brd, J = 11.0 Hz, 1H, H-2), 6.05 (dd, J = 11.0, 11.0 Hz, 1H, H-3), 4.76 (d, J = 4.0 Hz, 1H, H-5), 3.76–3.59 (m, 1H, H-4), 3.55 (s, 3H, OMe), 3.19 (s, 3H, NMe), 0.94 (d, J = 6.0 Hz, 3H, 4-Me), 0.91 (s, 9H, TBS), 0.00 (s, 3H, TBS), −0.22 (s, 3H, TBS); 13C{1H} NMR (125 MHz, CDCl3): δ 167.2 (C-1), 150.6 (C-3), 143.8 (Ar), 127.6 (Ar), 126.6 (Ar), 126.5 (Ar), 117.2 (C-2), 77.8 (C-5), 61.4 (OMe), 41.2 (C-4), 32.0 (NMe), 25.8 (TBS), 18.2 (TBS), 14.0 (4-Me), −4.6 (TBS), −5.1 (TBS); HRMS calcd for C20H33NO3SiNa [M + Na]+ 386.2122; found, 386.2105.
(4SR,5SR,2E)-5-((tert-Butyldimethylsilyl)oxy)-N-methoxy-N,4-dimethyl-5-phenylpent-2-enamide ((E)-16q)
Rf = 0.68 (silica gel, hexane/ethyl acetate = 2/1); FT-IR (neat) νmax: 2954, 2931, 2893, 2854, 1666, 1635, 1466, 1412, 1381, 1257, 1088, 1065, 841, 779, 702 cm–1; 1H NMR (500 MHz, CDCl3, δ): 7.32–7.17 (m, 5H, Ar), 6.99 (dd, J = 15.5, 8.5 Hz, 1H, H-3), 6.26 (d, J = 15.5 Hz, 1H, H-2), 4.53 (d, J = 5.5 Hz, 1H, H-5), 3.58 (s, 3H, OMe), 3.22 (s, 3H, NMe), 2.66–2.56 (m, 1H, H-4), 0.96 (d, J = 7.0 Hz, 3H, 4-Me), 0.86 (s, 9H, TBS), 0.02 (s, 3H, TBS), −0.22 (s, 3H, TBS); 13C{1H} NMR (125 MHz, CDCl3): δ 166.7 (C-1), 149.4 (C-3), 143.1 (Ar), 127.7 (Ar), 127.0 (Ar), 126.6 (Ar), 118.8 (C-2), 78.6 (C-5), 61.5 (OMe), 45.8 (C-4), 32.2 (NMe), 25.7 (TBS), 18.1 (TBS), 16.2 (4-Me), −4.7 (TBS), −5.1 (TBS); HRMS calcd for C20H33NO3SiNa [M + Na]+ 386.2122; found, 386.2122.
(4SR,5SR,2Z)-5-((tert-Butyldimethylsilyl)oxy)-N-methoxy-N,4-dimethyl-5-phenylpent-2-enamide ((Z)-16q)
Rf = 0.78 (silica gel, hexane/ethyl acetate = 2/1); FT-IR (neat) νmax: 2954, 2931, 2893, 2854, 1658, 1458, 1257, 1095, 1065, 1003, 856, 841, 779, 702 cm–1; 1H NMR (500 MHz, CDCl3, δ): 7.30–7.21 (m, 4H, Ar), 7.20–7.13 (m, 1H, Ar), 6.18 (brd, J = 11.0 Hz, 1H, H-2), 6.10 (dd, J = 11.0, 11.0 Hz, 1H, H-3), 4.61 (d, J = 5.5 Hz, 1H, H-5), 3.81–3.59 (m, 1H, H-4), 3.44 (s, 3H, OMe), 3.11 (s, 3H, NMe), 1.05 (d, J = 7.0 Hz, 3H, 4-Me), 0.90 (s, 9H, TBS), 0.06 (s, 3H, TBS), −0.21 (s, 3H, TBS); 13C{1H} NMR (125 MHz, CDCl3): δ 167.1 (C-1), 148.4 (C-3), 143.7 (Ar), 127.6 (Ar), 126.7 (Ar), 126.5 (Ar), 118.2 (C-2), 78.3 (C-5), 61.3 (OMe), 41.5 (C-4), 31.9 (NMe), 25.8 (TBS), 18.2 (TBS), 17.3 (4-Me), −4.6 (TBS), −5.1 (TBS); HRMS calcd for C20H33NO3SiNa [M + Na]+ 386.2122; found, 386.2132.
(2E)-N-Methoxy-N-methyl-3-((1RS,2SR)-2-phenylcyclopropyl)prop-2-enamide ((E)-16r)
Rf = 0.22 (silica gel, hexane/ethyl acetate = 2/1); FT-IR (neat) νmax: 3001, 2939, 1658, 1628, 1496, 1458, 1419, 1373, 1180, 1088, 1003, 964, 926, 748, 702 cm–1; 1H NMR (500 MHz, CDCl3, δ): 7.33–7.23 (m, 2H, Ar), 7.22–7.15 (m, 1H, Ar), 7.13–7.04 (m, 2H, Ar), 6.59 (dd, J = 15.0, 10.0 Hz, 1H, H-3), 6.50 (d, J = 15.0 Hz, 1H, H-2), 3.70 (s, 3H, OMe), 3.24 (s, 3H, NMe), 2.18 (ddd, J = 9.0, 6.0, 4.5 Hz, 1H, H-5), 1.93–1.82 (m, 1H, H-4), 1.44 (ddd, J = 8.0, 6.0, 5.5 Hz, 1H, CH2), 1.32 (ddd, J = 9.0, 6.0, 5.5 Hz, 1H, CH2); 13C{1H} NMR (125 MHz, CDCl3): δ 166.9 (C-1), 150.1 (C-3), 141.1 (Ar), 128.4 (Ar), 126.0 (Ar), 125.8 (Ar), 116.4 (C-2), 61.7 (OMe), 32.4 (NMe), 27.4 (C-4), 26.6 (C-5), 17.8 (CH2); HRMS calcd for C14H17NO2Na [M + Na]+ 254.1151; found, 254.1147.
(2Z)-N-Methoxy-N-methyl-3-((1RS,2SR)-2-phenylcyclopropyl)prop-2-enamide ((Z)-16r)
Rf = 0.44 (silica gel, hexane/ethyl acetate = 2/1); ATR-IR νmax: 1654, 1621, 1497, 1459, 1350, 1179, 1001, 751, 699 cm–1; 1H NMR (500 MHz, CDCl3, δ): 7.27–7.21 (m, 2H, Ar), 7.17–7.08 (m, 3H, Ar), 6.25 (brd, J = 11.0 Hz, 1H, H-2), 5.56 (dd, J = 11.0, 11.0 Hz, 1H, H-3), 3.69 (s, 3H, OMe), 3.41–3.27 (m, 1H, H-4), 3.21 (s, 3H, NMe), 2.05 (ddd, J = 9.0, 5.5, 4.5 Hz, 1H, H-5), 1.40 (ddd, J = 7.5, 5.5, 5.0 Hz, 1H, CH2), 1.17 (ddd, J = 9.0, 5.5, 5.0 Hz, 1H, CH2); 13C{1H} NMR (125 MHz, CDCl3): δ 167.7 (C-1), 150.6 (C-3), 141.1 (Ar), 128.3 (Ar), 126.0 (Ar), 125.8 (Ar), 115.5 (C-2), 61.5 (OMe), 32.0 (NMe), 27.1 (C-5), 23.7 (C-4), 18.6 (CH2); HRMS calcd for C14H17NO2Na [M + Na]+ 254.1151; found, 254.1141.
Substrate Scope of Unsaturated Aliphatic Aldehyde
(2E,4E)-N-Methoxy-N-methylhepta-2,4-dienamide ((E)-18a)
Rf = 0.39 (silica gel, hexane/ethyl acetate = 2/1); FT-IR (neat) νmax: 2970, 2939, 1658, 1628, 1612, 1381, 1003 cm–1; 1H NMR (500 MHz, CDCl3, δ): 7.32 (dd, J = 15.5, 10.0 Hz, 1H, H-3), 6.39 (d, J = 15.5 Hz, 1H, H-2), 6.23 (dd, J = 15.0, 10.0 Hz, 1H, H-4), 6.17 (dt, J = 15.0, 6.0 Hz, 1H, H-5), 3.71 (s, 3H, OMe), 3.25 (s, 3H, NMe), 2.20 (qd, J = 7.0, 6.0 Hz, 2H, H-6), 1.05 (t, J = 7.0 Hz, 3H, H-7); 13C{1H} NMR (125 MHz, CDCl3): δ 167.4 (C-1), 145.2 (C-5), 143.9 (C-3), 127.8 (C-4), 116.9 (C-2), 61.6 (OMe), 32.4 (NMe), 25.9 (C-6), 12.9 (C-7); HRMS calcd for C9H15NO2Na [M + Na]+ 192.0995; found, 192.0990.
(2Z,4E)-N-Methoxy-N-methylhepta-2,4-dienamide ((Z)-18a)
Rf = 0.58 (silica gel, hexane/ethyl acetate = 2/1); ATR-IR νmax: 2967, 2937, 1653, 1595, 1463, 1437, 1350, 1180, 1001 cm–1; 1H NMR (500 MHz, CDCl3, δ): 7.41 (dd, J = 15.0, 11.5 Hz, 1H, H-4), 6.51 (dd, J = 11.5, 11.5 Hz, 1H, H-3), 6.09 (d, J = 11.5 Hz, 1H, H-2), 6.05 (dt, J = 15.0, 7.0 Hz, 1H, H-5), 3.69 (s, 3H, OMe), 3.23 (s, 3H, NMe), 2.21 (qd, J = 7.5, 7.0 Hz, 2H, H-6), 1.05 (t, J = 7.5 Hz, 3H, H-7); 13C{1H} NMR (125 MHz, CDCl3): δ 167.5 (C-1), 145.9 (C-5), 143.4 (C-3), 126.3 (C-4), 113.7 (C-2), 61.6 (OMe), 32.1 (NMe), 26.0 (C-6), 13.1 (C-7); HRMS calcd for C9H15NO2Na [M + Na]+ 192.0995; found, 192.0993.
(2E,4E)-N-Methoxy-N,4-dimethylhepta-2,4-dienamide ((E)-18b)
Rf = 0.44 (silica gel, hexane/ethyl acetate = 2/1); ATR-IR νmax: 2967, 2936, 1659, 1609, 1463, 1416, 1379, 1004 cm–1; 1H NMR (500 MHz, CDCl3, δ): 7.36 (d, J = 15.5 Hz, 1H, H-3), 6.36 (d, J = 15.5 Hz, 1H, H-2), 5.90 (t, J = 7.5 Hz, 1H, H-5), 3.72 (s, 3H, OMe), 3.27 (s, 3H, NMe), 2.21 (dt, J = 7.5, 7.5 Hz, 2H, H-6), 1.81 (s, 3H, 4-Me), 1.03 (t, J = 7.5 Hz, 3H, H-7); 13C{1H} NMR (125 MHz, CDCl3): δ 167.7 (C-1), 148.5 (C-3), 143.1 (C-5), 132.4 (C-4), 112.9 (C-2), 61.6 (OMe), 32.4 (NMe), 22.0 (C-6), 13.5 (C-7), 12.2 (4-Me); HRMS calcd for C10H17NO2Na [M + Na]+ 206.1151; found, 206.1160.
(2E)-N-Methoxy-N-methyl-5-(trimethylsilyl)pent-2-en-4-ynamide ((E)-18c)
Rf = 0.55 (silica gel, hexane/ethyl acetate = 2/1); FT-IR (neat) νmax: 2962, 1658, 1604, 1381, 1250, 1057, 995, 849, 764 cm–1; 1H NMR (500 MHz, CDCl3, δ): 6.86 (d, J = 15.5 Hz, 1H, H-3), 6.78 (d, J = 15.5 Hz, 1H, H-2), 3.72 (s, 3H, OMe), 3.26 (s, 3H, NMe), 0.22 (s, 9H, TMS); 13C{1H} NMR (125 MHz, CDCl3): δ 165.6 (C-1), 128.7 (C-3), 123.5 (C-2), 103.4 (C-4), 102.3 (C-5), 62.0 (OMe), 32.3 (NMe), −0.4 (TMS); HRMS calcd for C20H34N2O4Si2Na [2 M + Na]+ 445.1949; found, 445.1969.
(2E,4E)-N-Methoxy-N-methyl-5-phenylpenta-2,4-dienamide ((E)-18d)
Rf = 0.38 (silica gel, hexane/ethyl acetate = 2/1); mp: 64.0 °C; FT-IR (KBr) νmax: 3433, 1643, 1604, 1381, 1018, 995, 694 cm–1; 1H NMR (500 MHz, C6D6, δ): 7.84 (dd, J = 15.0, 11.0 Hz, 1H, H-3), 7.22–7.12 (m, 2H, Ar), 7.12–6.97 (m, 3H, Ar), 6.72 (dd, J = 15.0, 11.0 Hz, 1H, H-4), 6.65 (d, J = 15.0 Hz, H-5), 6.51 (d, J = 15.0 Hz, 1H, H-2), 3.12 (s, 3H, OMe), 3.01 (s, 3H, NMe); 13C{1H} NMR (125 MHz, C6D6): δ 167.1 (C-1), 143.5 (C-3), 139.6 (C-5), 136.8 (Ar), 128.8 (Ar), 128.7 (Ar), 127.4 (Ar), 127.2 (C-4), 120.1 (C-2), 61.1 (OMe), 32.2 (NMe); HRMS calcd for C13H15NO2Na [M + Na]+ 240.0995; found, 240.1003.
(2Z,4E)-N-Methoxy-N-methyl-5-phenylpenta-2,4-dienamide ((Z)-18d, (2Z,4E)-18d)
Rf = 0.54 (silica gel, hexane/ethyl acetate = 2/1); mp: 61.7 °C; FT-IR (KBr) νmax: 3433, 1635, 1612, 1581, 1458, 1350, 995, 810, 756, 694 cm–1; 1H NMR (500 MHz, C6D6, δ): 8.87 (dd, J = 15.5, 11.5 Hz, 1H, H-4), 7.43–7.35 (m, 2H, Ar), 7.06–6.93 (m, 3H, Ar), 6.56 (d, J = 15.5 Hz, 1H, H-5), 6.51 (dd, J = 11.5, 11.5 Hz, 1H, H-3), 6.26 (d, J = 11.5 Hz, 1H, H-2), 3.06 (s, 3H, OMe), 2.95 (s, 3H, NMe); 13C{1H} NMR (125 MHz, C6D6): δ 167.4 (C-1), 143.0 (C-3), 140.5 (C-5), 137.1 (Ar), 128.9 (Ar), 128.7 (Ar), 127.7 (Ar), 126.3 (C-4), 116.3 (C-2), 61.0 (OMe), 31.9 (NMe); HRMS calcd for C13H15NO2Na [M + Na]+ 240.0995; found, 240.0990.
(2E,4Z)-4-Bromo-N-methoxy-N-methyl-5-phenylpenta-2,4-dienamide ((E)-18e)
Rf = 0.43 (silica gel, hexane/ethyl acetate = 2/1); mp: 75.8 °C; ATR-IR νmax: 2967, 1646, 1606, 1592, 1464, 1446, 1414, 1380, 1146, 1002, 968, 853, 755, 694, 522 cm–1; 1H NMR (500 MHz, CDCl3, δ): 7.82–7.73 (m, 2H, Ar), 7.51 (d, J = 14.5 Hz, 1H, H-3), 7.46–7.33 (m, 3H, Ar), 7.29 (s, 1H, H-5), 6.94 (d, J = 14.5 Hz, 1H, H-2), 3.78 (s, 3H, OMe), 3.31 (s, 3H, NMe); 13C{1H} NMR (125 MHz, CDCl3): δ 166.3 (C-1), 143.7 (C-3), 138.4 (C-5), 134.9 (Ar), 129.9 (Ar), 129.2 (Ar), 128.3 (Ar), 121.1 (C-4), 120.9 (C-2), 62.0 (OMe), 32.5 (NMe); HRMS calcd for C13H14BrNO2Na [M + Na]+ 318.0100; found, 318.0113.
(2E,4E,6E)-N-Methoxy-N-methyl-7-phenylhepta-2,4,6-trienamide ((E)-18f)
Rf = 0.27 (silica gel, hexane/ethyl acetate = 2/1); mp: 79.9 °C; FT-IR (KBr) νmax: 3433, 2931, 1635, 1589, 1458, 1419, 1381, 1173, 1018, 995, 949, 748, 687 cm–1; 1H NMR (500 MHz, C6D6, δ): 7.84 (dd, J = 15.0, 11.5 Hz, 1H, H-3), 7.35–6.95 (m, 5H, Ar), 6.64 (dd, J = 15.5, 11.5 Hz, 1H, H-6), 6.63 (d, J = 15.0 Hz, 1H, H-2), 6.35 (dd, J = 15.0, 11.5 Hz, 1H, H-5), 6.34 (d, J = 15.5 Hz, 1H, H-7), 6.25 (dd, J = 15.0, 11.5 Hz, 1H, H-4), 3.10 (s, 3H, OMe), 3.00 (s, 3H, NMe); 13C{1H} NMR (125 MHz, C6D6): δ 167.2 (C-1), 143.4 (C-3), 140.3 (C-5), 137.3 (Ar), 136.1 (C-7), 131.3 (C-4), 128.9 (Ar), 128.5 (C-6), 128.3 (Ar), 127.0 (Ar), 119.7 (C-2), 61.1 (OMe), 32.3 (NMe); HRMS calcd for C30H34N2O4Na [2 M + Na]+ 509.2411; found, 509.2429.
(2Z,4E,6E)-N-Methoxy-N-methyl-7-phenylhepta-2,4,6-trienamide ((Z)-18f)
Rf = 0.47 (silica gel, hexane/ethyl acetate = 2/1); FT-IR (neat) νmax: 2970, 2931, 1643, 1597, 1566, 1435, 1350, 1180, 1095, 1003, 802, 756, 694 cm–1; 1H NMR (500 MHz, C6D6, δ): 8.42 (dd, J = 15.0, 11.5 Hz, 1H, H-4), 7.15–7.05 (m, 4H, Ar), 7.05–6.98 (m, 1H, Ar), 6.75 (dd, J = 15.5, 11.0 Hz, 1H, H-6), 6.49 (dd, J = 11.5, 11.5 Hz, 1H, H-3), 6,43 (d, J = 15.5 Hz, 1H, H-7), 6.38 (dd, J = 15.0, 11.0 Hz, 1H, H-5), 6.26 (d, J = 11.5 Hz, 1H, H-2 Hz), 3.06 (s, 3H, OMe), 2.96 (s, 3H, NMe); 13C{1H} NMR (125 MHz, C6D6): δ 167.4 (C-1), 142.8 (C-3), 141.0 (C-5), 137.3 (Ar), 135.9 (C-7), 130.7 (C-4), 129.3 (C-6), 128.8 (Ar), 128.1 (Ar), 127.2 (Ar). 115.8 (C-2), 61.0 (OMe), 32.0 (NMe); HRMS calcd for C30H34N2O4Na [2 M + Na]+ 509.2411; found, 509.2435.
Substrate Scope of Aromatic Aldehyde
(2E)-N-Methoxy-N-methyl-3-phenylprop-2-enamide ((E)-5b, (E)-20a)
Rf = 0.36 (silica gel, hexane/ethyl acetate = 2/1); mp: 36.6 °C; FT-IR (KBr) νmax: 2939, 1651, 1612, 1574, 1381, 1173, 995, 756, 532 cm–1; 1H NMR (500 MHz, CDCl3, δ): 7.74 (d, J = 15.5 Hz, 1H, H-3), 7.63–7.54 (m, 2H, Ar), 7.44–7.33 (m, 3H, Ar), 7.05 (d, J = 15.5 Hz, 1H, H-2), 3.78 (s, 3H, OMe), 3.32 (s, 3H, NMe); 13C{1H} NMR (125 MHz, CDCl3): δ 166.9 (C-1), 143.4 (C-3), 135.1 (Ar), 129.8 (Ar), 128.8 (Ar), 128.0 (Ar), 115.7 (C-2), 61.9 (OMe), 32.5 (NMe); HRMS calcd for C11H13NO2Na [M + Na]+ 214.0838; found, 214.0840.
(2E)-N-Methoxy-N-methyl-3-(2-methylphenyl)-prop-2-enamide ((E)-20b)
Rf = 0.32 (silica gel, hexane/ethyl acetate = 2/1); FT-IR (neat) νmax: 2962, 2939, 1658, 1620, 1481, 1458, 1412, 1381, 1003, 764 cm–1; 1H NMR (500 MHz, CDCl3, δ): 8.02 (d, J = 15.5 Hz, 1H, H-3), 7.65–7.58 (m, 1H, Ar), 7.32–7.17 (m, 3H, Ar), 6.95 (d, J = 15.5 Hz, 1H, H-2), 3.77 (s, 3H, OMe), 3.32 (s, 3H, NMe), 2.45 (s, 3H, ArMe); 13C{1H} NMR (125 MHz, CDCl3): δ 166.9 (C-1), 141.1 (C-3), 137.6 (Ar), 134.2 (Ar), 130.7 (Ar), 129.5 (Ar), 126.3 (Ar), 126.1 (Ar), 116.9 (C-2), 61.8 (OMe), 32.4 (NMe), 19.8 (ArMe); HRMS calcd for C24H30N2O4Na [2 M + Na]+ 433.2098; found, 433.2100.
(2E)-N-Methoxy-N-methyl-3-(3-methylphenyl)-prop-2-enamide ((E)-20c)
Rf = 0.52 (silica gel, hexane/ethyl acetate = 1/1); ATR-IR νmax: 2965, 2936, 1660, 1622, 1485, 1462, 1423, 1381, 1177, 1100, 997, 787 cm–1; 1H NMR (500 MHz, CDCl3, δ): 7.71 (d, J = 16.0 Hz, 1H, H-3), 7.41–7.35 (m, 2H, Ar), 7.31–7.23 (m, 1H, Ar), 7.22–7.15 (m, 1H, Ar), 7.02 (d, J = 16.0 Hz, 1H, H-2), 3.77 (s, 3H, OMe), 3.31 (s, 3H, NMe), 2.38 (s, 3H, ArMe); 13C{1H} NMR (125 MHz, CDCl3): δ 167.0 (C-1), 143.6 (C-3), 138.4 (Ar), 135.1 (Ar), 130.6 (Ar), 128.64 (Ar), 128.61 (Ar), 125.2 (Ar), 115.5 (C-2), 61.9 (OMe), 32.5 (NMe), 21.3 (ArMe); HRMS calcd for C12H15NO2Na [M + Na]+ 228.0995; found, 228.0997.
(2E)-N-Methoxy-N-methyl-3-(4-methylphenyl)-prop-2-enamide ((E)-20d)
Rf = 0.31 (silica gel, hexane/ethyl acetate = 2/1); mp: 50.2 °C; FT-IR (KBr) νmax: 3464, 3433, 2970, 2939, 1651, 1612, 1381, 1180, 987, 810, 494 cm–1; 1H NMR (500 MHz, CDCl3, δ): 7.71 (d, J = 15.5 Hz, 1H, H-3), 7.51–7.44 (m, 2H, Ar), 7.23–7.15 (m, 2H, Ar), 7.00 (d, J = 15.5 Hz, 1H, H-2), 3.77 (s, 3H, OMe), 3.31 (s, 3H, NMe), 2.38 (s, 3H, ArMe); 13C{1H} NMR (125 MHz, CDCl3): δ 167.1 (C-1), 143.4 (C-3), 140.1 (Ar), 132.4 (Ar), 129.5 (Ar), 128.0 (Ar), 114.6 (C-2), 61.8 (OMe), 32.5 (NMe), 21.4 (ArMe); HRMS calcd for C24H30N2O4Na [2 M + Na]+ 433.2098; found, 433.2094.
(2E)-N-Methoxy-N-methyl-3-(2,6-dimethylphenyl)-prop-2-enamide ((E)-20e)
Rf = 0.60 (silica gel, hexane/ethyl acetate = 1/1); FT-IR (neat) νmax: 2962, 2939, 1658, 1628, 1466, 1412, 1381, 1180, 995, 771 cm–1; 1H NMR (500 MHz, CDCl3, δ): 7.85 (d, J = 16.0 Hz, 1H, H-3), 7.17–7.04 (m, 3H, Ar), 6.66 (d, J = 16.0 Hz, 1H, H-2), 3.72 (s, 3H, OMe), 3.32 (s, 3H, NMe), 2.36 (s, 6H, ArMe); 13C{1H} NMR (125 MHz, CDCl3): δ 166.7 (C-1), 141.8 (C-3), 136.5 (Ar), 135.0 (Ar), 128.0 (Ar), 127.9 (Ar), 121.7 (C-2), 61.9 (OMe), 32.4 (NMe), 21.0 (ArMe); HRMS calcd for C26H34N2O4Na [2 M + Na]+ 461.2411; found, 461.2431.
(2E)-N-Methoxy-N-methyl-3-(4-bromophenyl)-prop-2-enamide ((E)-20f)
Rf = 0.45 (silica gel, hexane/ethyl acetate = 1/1); ATR-IR νmax: 1661, 1623, 1489, 1417, 1382, 1072, 1010, 818 cm–1; 1H NMR (500 MHz, CDCl3, δ): 7.66 (d, J = 15.5 Hz, 1H, H-3), 7.55–7.48 (m, 2H, Ar), 7.47–7.39 (m, 2H, Ar), 7.02 (d, J = 15.5 Hz, 1H, H-2), 3.77 (s, 3H, OMe), 3.31 (s, 3H, NMe); 13C{1H} NMR (125 MHz, CDCl3): δ 166.6 (C-1), 142.0 (C-3), 134.0 (Ar), 132.0 (Ar), 129.4 (Ar), 123.9 (Ar), 116.4 (C-2), 61.9 (OMe), 32.5 (NMe); HRMS calcd for C11H12BrNO2Na [M + Na]+ 291.9944; found, 291.9932.
(2E)-N-Methoxy-N-methyl-3-(4-methoxyphenyl)-prop-2-enamide ((E)-20g)
Rf = 0.29 (silica gel, hexane/ethyl acetate = 2/1); FT-IR (neat) νmax: 2962, 2939, 1651, 1604, 1512, 1381, 1250, 1173, 1034, 1003, 825 cm–1; 1H NMR (500 MHz, CDCl3, δ): 7.70 (d, J = 15.5 Hz, 1H, H-3), 7.57–7.50 (m, 2H, Ar), 6.95–6.88 (m, 2H, Ar), 6.92 (d, J = 15.5 Hz, 1H, H-2), 3.84 (s, 3H, ArOMe), 3.77 (s, 3H, NOMe), 3.31 (s, 3H, NMe); 13C{1H} NMR (125 MHz, CDCl3): δ 167.3 (C-1), 160.9 (Ar), 143.0 (C-3), 129.6 (Ar), 127.8 (Ar), 114.1 (C-2), 113.2 (Ar), 61.8 (OMe), 55.3 (ArOMe), 32.5 (NMe); HRMS calcd for C24H30N2O6Na [2 M + Na]+ 465.1996; found, 465.1985.
(2E)-N-Methoxy-N-methyl-3-(4-dimethylaminophenyl)-prop-2-enamide ((E)-20h)
Rf = 0.34 (silica gel, hexane/ethyl acetate = 1/1); FT-IR (neat) νmax: 2931, 2900, 1651, 1597, 1527, 1435, 1412, 1365, 1180, 1003, 818 cm–1; 1H NMR (500 MHz, CDCl3, δ): 7.68 (d, J = 16.0 Hz, 1H, H-3), 7.52–7.44 (m, 2H, Ar), 6.83 (d, J = 16.0 Hz, 1H, H-2), 6.71–6.64 (m, 2H, Ar), 3.76 (s, 3H, OMe), 3.30 (s, 3H, NMe), 3.02 (s, 6H, NMe2); 13C{1H} NMR (125 MHz, CDCl3): δ 168.0 (C-1), 151.4 (Ar), 143.9 (C-3), 129.6 (Ar), 123.0 (Ar), 111.7 (C-2), 110.2 (Ar), 61.7 (OMe), 40.1 (NMe2), 32.5 (NMe); HRMS calcd for C26H36N4O4Na [2 M + Na]+ 491.2629; found, 491.2642.
(2E)-N-Methoxy-N-methyl-3-(4-nitrophenyl)-prop-2-enamide ((E)-20i)
Rf = 0.34 (silica gel, hexane/ethyl acetate = 1/1); mp: 154.0 °C; FT-IR (KBr) νmax: 3471, 3024, 2939, 1651, 1620, 1589, 1520, 1342, 1173, 995, 849, 748 cm–1; 1H NMR (500 MHz, CDCl3, δ): 8.28–8.23 (m, 2H, Ar), 7.76 (d, J = 16.0 Hz, 1H, H-3), 7.74–7.69 (m, 2H, Ar), 7.17 (d, J = 16.0 Hz, 1H, H-2), 3.80 (s, 3H, OMe), 3.34 (s, 3H, NMe); 13C{1H} NMR (125 MHz, CDCl3): δ 165.8 (C-1), 148.2 (Ar), 141.3 (Ar), 140.5 (C-3), 128.6 (Ar), 124.1 (Ar), 120.0 (C-2), 62.1 (OMe), 32.5 (NMe); HRMS calcd for C11H12N2O4Na [M + Na]+ 259.0689; found, 259.0683.
(2E)-N-Methoxy-N-methyl-3-(4-trifluoromethylphenyl)-prop-2-enamide ((E)-20j)
Rf = 0.33 (silica gel, hexane/ethyl acetate = 2/1); mp: 55.8 °C; FT-IR (KBr) νmax: 3464, 2939, 1658, 1620, 1327, 1165, 1126, 1065, 995, 833 cm–1; 1H NMR (500 MHz, CDCl3, δ): 7.74 (d, J = 16.0 Hz, 1H, H-3), 7.67 (d, J = 8.5 Hz, 2H, Ar), 7.64 (d, J = 8.5 Hz, 2H, Ar), 7.11 (d, J = 16.0 Hz, 1H, H-2), 3.78 (s, 3H, OMe), 3.33 (s, 3H, NMe); 13C{1H} NMR (125 MHz, CDCl3): δ 166.2 (C-1), 141.6 (C-3), 138.6 (Ar), 131.3 (q, 2JCF = 32.3 Hz, Ar), 128.1 (Ar), 125.7 (q, 3JCF = 3.6 Hz, Ar), 123.9 (q, 1JCF = 270.6 Hz, CF3), 118.3 (C-2), 62.0 (OMe), 32.5 (NMe); 19F{1H, 13C} NMR (470 MHz, CDCl3): −63.2 (CF3); HRMS calcd for C12H12F3NO2Na [M + Na]+ 282.0712; found, 282.0721.
(2E)-N-Methoxy-N-methyl-3-(4-cyanophenyl)-prop-2-enamide ((E)-20k)
Rf = 0.33 (silica gel, hexane/ethyl acetate = 1/1); mp: 151.6 °C; ATR-IR νmax: 2978, 2224, 1655, 1618, 1470, 1412, 1383, 1008, 831, 548 cm–1; 1H NMR (500 MHz, CDCl3, δ): 7.72–7.61 (m, 4H, Ar), 7.71 (d, J = 15.5 Hz, 1H, H-3), 7.12 (d, J = 15.5 Hz, 1H, H-2), 3.78 (s, 3H, OMe), 3.33 (s, 3H, NMe); 13C{1H} NMR (125 MHz, CDCl3): δ 165.9 (C-1), 141.0 (C-3), 139.5 (Ar), 132.5 (Ar), 128.4 (Ar), 119.3 (C-2), 118.5 (CN), 112.9 (Ar), 62.0 (OMe), 32.5 (NMe); HRMS calcd for C12H12N2O2Na [M + Na]+ 239.0791; found, 239.0790.
Methyl (2E)-4-(3-(methoxy(methyl)amino)-3-oxoprop-1-en-1-yl)benzoate ((E)-20l)
Rf = 0.18 (silica gel, hexane/ethyl acetate = 2/1); mp: 88.8 °C; FT-IR (KBr) νmax: 3417, 2947, 1720, 1651, 1612, 1566, 1442, 1412, 1381, 1281, 1173, 1095, 995, 771 cm–1; 1H NMR (500 MHz, CDCl3, δ): 8.12–8.00 (m, 2H, Ar), 7.75 (d, J = 16.0 Hz, 1H, H-3), 7.68–7.58 (m, 2H, Ar), 7.12 (d, J = 16.0 Hz, 1H, H-2), 3.93 (s, 3H, COOMe), 3.79 (s, 3H, NOMe), 3.32 (s, 3H, NMe); 13C{1H} NMR (125 MHz, CDCl3): δ 166.5 (COOMe), 166.3 (C-1), 142.0 (C-3), 139.4 (Ar), 130.9 (Ar), 130.0 (Ar), 127.8 (Ar), 118.1 (C-2), 62.0 (NOMe), 52.2 (COOMe), 32.5 (NMe); HRMS calcd for C13H15NO4Na [M + Na]+ 272.0893; found, 272.0883.
(2E)-3-(4-Methoxy(methyl)carbamoylphenyl)-N-methoxy-N-methylprop-2-enamide ((E)-20m)
Rf = 0.28 (silica gel, hexane/ethyl acetate = 1/2); mp: 79.5 °C; ATR-IR νmax: 1652, 1622, 1556, 1455, 1424, 1385, 1208, 1186, 1005, 976, 851 cm–1; 1H NMR (500 MHz, CDCl3, δ): 7.75–7.68 (m, 2H, Ar), 7.74 (d, J = 15.5 Hz, 1H, H-3), 7.64–7.57 (m, 2H, Ar), 7.09 (d, J = 15.5 Hz, 1H, H-2), 3.78 (s, 3H, 1NOMe), 3.56 (s, 3H, 4′NOMe), 3.37 (s, 3H, 4′NMe), 3.32 (s, 3H, 1NMe); 13C{1H} NMR (125 MHz, CDCl3): δ 169.1 (C-4′), 166.5 (C-1), 142.3 (C-3), 137.2 (Ar), 135.0 (Ar), 128.7 (Ar), 127.5 (Ar), 117.3 (C-2), 61.9 (1NOMe), 61.1 (4′NOMe), 33.5 (4′NMe), 32.5 (1NMe); HRMS calcd for C14H18N2O4Na [M + Na]+ 301.1159; found, 301.1151.
(2E)-N-Methoxy-N-methyl-3-(4-acetylphenyl)-prop-2-enamide ((E)-20n)
Rf = 0.17 (silica gel, hexane/ethyl acetate = 2/1); FT-IR (neat) νmax: 2970, 2939, 1682, 1658, 1620, 1419, 1381, 1365, 1265, 1180, 995, 957, 825 cm–1; 1H NMR (500 MHz, CDCl3, δ): 8.01–7.94 (m, 2H, Ar), 7.75 (d, J = 15.5 Hz, 1H, H-3), 7.68–7.62 (m, 2H, Ar), 7.12 (d, J = 15.5 Hz, 1H, H-2), 3.79 (s, 3H, OMe), 3.33 (s, 3H, NMe), 2.62 (s, 3H, COCH3); 13C{1H} NMR (125 MHz, CDCl3): δ 197.3 (COCH3), 166.3 (C-1), 141.9 (C-3), 139.5 (Ar), 137.6 (Ar), 128.8 (Ar), 128.1 (Ar), 118.3 (C-2), 62.0 (OMe), 32.5 (NMe), 26.6 (COCH3); HRMS calcd for C13H15NO3Na [M + Na]+ 256.0944; found, 256.0932.
(2E)-4-(3-(Methoxy(methyl)amino)-3-oxoprop-1-en-1-yl)benzoic Acid ((E)-20o)
Rf = 0.58 (silica gel, chloroform/methanol/acetic acid = 90/10/1); mp: 172.7 °C; ATR-IR νmax: 1686, 1655, 1616, 1420, 1388, 1315, 1295, 771 cm–1; 1H NMR (500 MHz, dimethyl sulfoxide-d6, δ): 7.96 (d, J = 8.0 Hz, 2H, Ar), 7.81 (d, J = 8.0 Hz, 2H, Ar), 7.61 (d, J = 15.0 Hz, 1H, H-3), 7.20 (d, J = 15.0 Hz, 1H, H-2), 3.75 (s, 3H, OMe), 3.22 (s, 3H, NMe); 13C{1H} NMR (125 MHz, dimethyl sulfoxide-d6, δ): 167.3 (COOH), 165.5 (C-1), 141.2 (C-3), 138.4 (Ar), 132.8 (Ar), 129.7 (Ar), 128.1 (Ar), 118.5 (C-2), 61.9 (OMe), 32.2 (NMe); HRMS calcd for C12H12NO4Na [M + Na]+ 234.0761; found, 234.0756.
(2E)-N-Methoxy-N-methyl-3-(4-hydroxyphenyl)-prop-2-enamide ((E)-20p)
Rf = 0.32 (silica gel, hexane/ethyl acetate = 1/1); mp: 147.5 °C; ATR-IR νmax: 3100, 3008, 1645, 1576, 1515, 1282, 830 cm–1; 1H NMR (500 MHz, CDCl3, δ): 7.68 (d, J = 16.0 Hz, 1H, H-3), 7.64 (s, 1H, OH), 7.47–7.40 (m, 2H, Ar), 6.92–6.87 (m, 2H, Ar), 6.89 (d, J = 16.0 Hz, 1H, H-2), 3.77 (s, 3H, OMe), 3.33 (s, 3H, NMe); 13C{1H} NMR (125 MHz, CDCl3): δ 167.6 (C-1), 158.1 (Ar), 143.8 (C-3), 129.9 (Ar), 127.4 (Ar), 115.9 (Ar), 112.6 (C-2), 61.9 (OMe), 32.6 (NMe); HRMS calcd for C11H13NO3Na [M + Na]+ 230.0788; found, 230.0777.
(2E)-N-Methoxy-N-methyl-3-(4-boronophenyl)-prop-2-enamide ((E)-20q)
Rf = 0.55 (silica gel, chloroform/methanol/acetic acid = 90/10/1); mp: 247.1 °C; ATR-IR νmax: 3369, 1647, 1606, 1554, 1463, 1409, 1375, 1349, 1047, 829 cm–1; 1H NMR (500 MHz, acetone-d6, δ): 7.92 (d, J = 8.0 Hz, 2H, Ar), 7.66 (d, J = 8.0 Hz, 2H, Ar), 7.64 (d, J = 15.0 Hz, 1H, H-3), 7.31–7.25 (m, 2H, B(OH)2), 7.20 (d, J = 15.0 Hz, 1H, H-2), 3.81 (s, 3H, OMe), 3.24 (s, 3H, NMe); 13C{1H} NMR (125 MHz, acetone-d6, δ): 167.1 (C-1), 143.2 (C-3), 137.8 (Ar), 135.4 (Ar), 127.902 (Ar), 117.8 (C-2), 62.3 (OMe), 32.5 (NMe); HRMS calcd for C11H14BNO4Na [M + Na]+ 258.0910; found, 258.0908.
(2E)-N-Methoxy-N-methyl-3-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-prop-2-enamide ((E)-20r)
Rf = 0.56 (silica gel, hexane/ethyl acetate = 1/1); mp: 108.5 °C; ATR-IR νmax: 2989, 1653, 1623, 1421, 1399, 1383, 1362, 1330, 1147, 1089, 998, 829, 646 cm–1; 1H NMR (500 MHz, CDCl3, δ): 7.86–7.78 (m, 2H, Ar), 7.74 (d, J = 16.0 Hz, 1H, H-3), 7.59–7.53 (m, 2H, Ar), 7.08 (d, J = 16.0 Hz, 1H, H-2), 3.78 (s, 3H, OMe), 3.32 (s, 3H, NMe), 1.35 (s, 12H, Bpin); 13C{1H} NMR (125 MHz, CDCl3): δ 166.8 (C-1), 143.3 (C-3), 137.6 (Ar), 135.14 (Ar), 135.13 (Ar), 127.2 (Ar), 116.6 (C-2), 83.9 (Bpin), 61,9 (OMe), 32.5 (NMe), 24.8 (Bpin); HRMS calcd for C17H24BNO4Na [M + Na]+ 340.1694; found, 340.1684.
(2E)-N-Methoxy-N-methyl-3-(pyridin-2-yl)-prop-2-enamide ((E)-20s)
Rf = 0.53 (silica gel, diethyl ether/methanol = 12/1); ATR-IR νmax: 2936, 1661, 1623, 1586, 1471, 1435, 1416, 1384, 993, 783 cm–1; 1H NMR (500 MHz, CDCl3, δ): 8.69–8.63 (m, 1H, Py), 7.75–7.67 (m, 1H, Py), 7.72 (d, J = 15.0 Hz, 1H, H-3), 7.56 (d, J = 15.0 Hz, 1H, H-2), 7.44–7.38 (m, 1H, Py), 7.28–7.22 (m, 1H, Py), 3.80 (s, 3H, OMe), 3.33 (s, 3H, NMe); 13C{1H} NMR (125 MHz, CDCl3): δ 166.6 (C-1), 153.4 (Py), 150.0 (Py), 141.9 (C-3), 136.7 (Py), 124.8 (Py), 123.9 (Py), 120.0 (C-2), 62.0 (OMe), 32.5 (NMe); HRMS calcd for C10H12N2O2Na [M + Na]+ 215.0791; found, 215.0788.
(2E)-N-Methoxy-N-methyl-3-(pyridin-3-yl)-prop-2-enamide ((E)-20t)
Rf = 0.71 (silica gel, chloroform/methanol = 9/1); mp: 66.9 °C; FT-IR (KBr) νmax: 3464, 3433, 1643, 1612, 1381, 995, 810 cm–1; 1H NMR (500 MHz, CDCl3, δ): 8.83–8.78 (m, 1H, Py), 8.62–8.57 (m, 1H, Py), 7.91–7.85 (m, 1H, Py), 7.72 (d, J = 16.0 Hz, 1H, H-3), 7.37–7.31 (m, 1H, Py), 7.12 (d, J = 16.0 Hz, 1H, H-2), 3.79 (s, 3H, OMe), 3.33 (s, 3H, NMe); 13C{1H} NMR (125 MHz, CDCl3): δ 166.1 (C-1), 150.5 (Py), 149.5 (Py), 139.7 (C-3), 134.4 (Py), 130.9 (Py), 123.6 (Py), 117.9 (C-2), 62.0 (OMe), 32.5 (NMe); HRMS calcd for C20H24N4O4Na [2 M + Na]+ 407.1690; found, 407.1685.
(2E)-N-Methoxy-N-methyl-3-(pyridin-4-yl)-prop-2-enamide ((E)-20u)
Rf = 0.70 (silica gel, chloroform/methanol = 9/1); mp: 97.6 °C; FT-IR (KBr) νmax: 3433, 2962, 2939, 1651, 1620, 1597, 1550, 1450, 1419, 1381, 1203, 1180, 995, 957, 825, 548, 501 cm–1; 1H NMR (500 MHz, CDCl3, δ): 8.65 (dd, J = 6.5, 0.5 Hz, 2H, Py), 7.65 (d, J = 16.0 Hz, 1H, H-3), 7.42 (dd, J = 6.5, 0.5 Hz, 2H, Py), 7.20 (d, J = 16.0 Hz, 1H, H-2), 3.79 (s, 3H, OMe), 3.33 (s, 3H, NMe); 13C{1H} NMR (125 MHz, CDCl3): δ 165.8 (C-1), 150.5 (Py), 142.3 (Py), 140.5 (C-3), 121.8 (Py), 120.3 (C-2), 62.0 (OMe), 32.5 (NMe); HRMS calcd for C20H24N4O4Na [2 M + Na]+ 407.1690; found, 407.1702.
(2E)-N-Methoxy-N-methyl-3-(furan-2-yl)-prop-2-enamide ((E)-20v)
Rf = 0.45 (silica gel, hexane/ethyl acetate = 1/1); FT-IR (neat) νmax: 2939, 1658, 1620, 1481, 1412, 1381, 1003, 980, 748 cm–1; 1H NMR (500 MHz, CDCl3, δ): 7.48 (d, J = 15.5 Hz, 1H, H-3), 7.47 (d, J = 2.0 Hz, 1H, furan), 6.91 (d, J = 15.5 Hz, 1H, H-2), 6.59 (d, J = 3.5 Hz, 1H, furan), 6.46 (dd, J = 3.5, 2.0 Hz, 1H, furan), 3.76 (s, 3H, OMe), 3.30 (s, 3H, NMe); 13C{1H} NMR (125 MHz, CDCl3): δ 167.0 (C-1), 151.7 (furan), 144.1 (furan), 129.9 (C-3), 114.3 (furan), 113.6 (C-2), 112.2 (furan), 61.9 (OMe), 32.5 (NMe); HRMS calcd for C9H11NO3Na [M + Na]+ 204.0631; found, 204.0623.
(2E)-N-Methoxy-N-methyl-3-(thiophen-2-yl)-prop-2-enamide ((E)-20w)
Rf = 0.48 (silica gel, hexane/ethyl acetate = 1/1); FT-IR (neat) νmax: 2939, 1651, 1612, 1412, 1381, 1350, 1196, 1003, 972, 825, 710 cm–1; 1H NMR (500 MHz, CDCl3, δ): 7.83 (d, J = 15.5 Hz, 1H, H-3), 7.37–7.32 (m, 1H, thiophene), 7.28–7.23 (m, 1H, thiophene), 7.08–7.03 (m, 1H, thiophene), 6.82 (d, J = 15.5 Hz, 1H, H-2), 3.76 (s, 3H, OMe), 3.30 (s, 3H, NMe); 13C{1H} NMR (125 MHz, CDCl3): δ 166.7 (C-1), 140.4 (thiophene), 135.9 (C-3), 130.6 (thiophene), 128.0 (thiophene), 127.5 (thiophene), 114.7 (C-2), 61.9 (OMe), 32.5 (NMe); HRMS calcd for C9H11NO2SNa [M + Na]+ 220.0403; found, 220.0393.
(2E)-N-Methoxy-N-methyl-3-(1H-pyrrol-2-yl)-prop-2-enamide ((E)-20x)
Rf = 0.27 (silica gel, hexane/ethyl acetate = 1/1); FT-IR (neat) νmax: 3394, 3255, 1643, 1589, 1550, 1404, 1381, 1034, 1003, 741 cm–1; 1H NMR (500 MHz, CDCl3, δ): 9.10–8.80 (m, 1H, NH), 7.64 (d, J = 15.5 Hz, 1H, H-3), 6.95–6.87 (m, 1H, pyrrole), 6.64 (d, J = 15.5 Hz, 1H, H-2), 6.62–6.56 (m, 1H, pyrrole), 6.32–6.25 (m, 1H, pyrrole), 3.74 (s, 3H, OMe), 3.30 (s, 3H, NMe); 13C{1H} NMR (125 MHz, CDCl3): δ 167.7 (C-1), 133.3 (C-3), 129.2 (pyrrole), 121.6 (pyrrole), 113.1 (pyrrole), 110.8 (pyrrole), 109.2 (C-2), 61.8 (OMe), 32.6 (NMe); HRMS calcd for C9H12N2O2Na [M + Na]+ 203.0791; found, 203.0789.
(2E)-N-Methoxy-N-methyl-3-(1-methyl-1H-pyrrol-2-yl)-prop-2-enamide ((E)-20y)
Rf = 0.19 (silica gel, hexane/ethyl acetate = 1/1); FT-IR (neat) νmax: 3471, 2939, 1643, 1604, 1481, 1404, 1373, 1180, 1095, 1057, 1003, 972, 733 cm–1; 1H NMR (500 MHz, CDCl3, δ): 7.65 (d, J = 15.5 Hz, 1H, H-3), 6.76–6.66 (m, 2H, pyrrole), 6.75 (d, J = 15.5 Hz, 1H, H-2), 6.21–6.14 (m, 1H, pyrrole), 3.74 (s, 3H, OMe), 3.72 (s, 3H, NMe), 3.29 (s, 3H, CONMe); 13C{1H} NMR (125 MHz, CDCl3): δ 167.8 (C-1), 131.1 (C-3), 130.1 (pyrrole), 126.2 (pyrrole), 110.8 (pyrrole), 110.7 (C-2), 109.0 (pyrrole), 61.7 (OMe), 34.3 (NMe), 32.5 (CONMe); HRMS calcd for C10H14N2O2Na [M + Na]+ 217.0947; found, 217.0947.
(2E)-N-Methoxy-N-methyl-3-(1H-indol-3-yl)-prop-2-enamide ((E)-20z)
Rf = 0.18 (silica gel, hexane/ethyl acetate = 1/1); mp: 152.8 °C; ATR-IR νmax: 3157, 2970, 2927, 1634, 1570, 1417, 1386, 1246, 745 cm–1; 1H NMR (500 MHz, CDCl3, δ): 9.08–8.91 (m, 1H, NH), 7.97 (d, J = 16.0 Hz, 1H, H-3), 7.96–7.89 (m, 1H, indole), 7.52–7.46 (m, 1H, indole), 7.46–7.39 (m, 1H, indole), 7.31–7.20 (m, 2H, indole), 7.07 (d, J = 16.0 Hz, 1H, H-2), 3.82 (s, 3H, OMe), 3.34 (s, 3H, NMe); 13C{1H} NMR (125 MHz, CDCl3): δ 168.5 (C-1), 137.2 (indole), 137.1 (C-3), 128.9 (indole), 125.4 (indole), 123.1 (indole), 121.2 (indole), 120.4 (indole), 114.0 (indole), 111.9 (indole), 111.0 (C-2), 61.7 (OMe), 32.6 (NMe); HRMS calcd for C13H14N2O2Na [M + Na]+ 253.0947; found, 253.0937.
(2E)-N-Methoxy-N-methyl-3-(naphthalen-1-yl)-prop-2-enamide ((E)-20aa)
Rf = 0.53 (silica gel, hexane/ethyl acetate = 1/1); mp: 68.7 °C; FT-IR (KBr) νmax: 3464, 3433, 3402, 1643, 1612, 1419, 1381, 1173, 995, 795, 771 cm–1; 1H NMR (500 MHz, CDCl3, δ): 8.57 (d, J = 15.5 Hz, 1H, H-3), 8.30–8.20 (m, 1H, naphthalene), 7.94–7.84 (m, 2H, naphthalene), 7.82–7.74 (m, 1H, naphthalene), 7.63–7.44 (m, 3H, naphthalene), 7.01 (d, J = 15.5 Hz, 1H, H-2), 3.79 (s, 3H, OMe), 3.36 (s, 3H, NMe); 13C{1H} NMR (125 MHz, CDCl3): δ 166.8 (C-1), 140.5 (C-3), 133.6 (naphthalene), 132.7 (naphthalene), 131.5 (naphthalene), 130.0 (naphthalene), 128.6 (naphthalene), 126.7 (naphthalene), 126.1 (naphthalene), 125.3 (naphthalene), 124.7 (naphthalene), 123.7 (naphthalene), 118.7 (C-2), 61.9 (OMe), 32.5 (NMe); HRMS calcd for C15H15NO2Na [M + Na]+ 264.0995; found, 264.1007.
(2E)-N-Methoxy-N-methyl-3-(anthracen-9-yl)-prop-2-enamide ((E)-20ab)
Rf = 0.56 (silica gel, hexane/ethyl acetate = 1/1); FT-IR (neat) νmax: 3055, 2970, 2939, 1658, 1628, 1442, 1419, 1381, 1180, 995, 887, 779, 741, 702 cm–1; 1H NMR (500 MHz, CDCl3, δ): 8.66 (d, J = 16.0 Hz, 1H, H-3), 8.47–8.41 (m, 1H, anthracene), 8.33–8.24 (m, 2H, anthracene), 8.06–7.95 (m, 2H, anthracene), 7.54–7.44 (m, 4H, anthracene), 7.00 (d, J = 16.0 Hz, 1H, H-2), 3.72 (s, 3H, OMe), 3.40 (s, 3H, NMe); 13C{1H} NMR (125 MHz, CDCl3): δ 166.4 (C-1), 140.6 (C-3), 131.3 (anthracene), 130.5 (anthracene), 129.4 (anthracene), 128.7 (anthracene), 127.7 (anthracene), 126.0 (anthracene), 125.5 (anthracene), 125.3 (anthracene), 125.1 (C-2), 62.0 (OMe), 32.6 (NMe); HRMS calcd for C19H17NO2Na [M + Na]+ 314.1151; found, 314.1155.
(2E)-N-Methoxy-N-methyl-3-(2-formylphenyl)-prop-2-enamide ((E)-20ac)
Rf = 0.45 (silica gel, hexane/ethyl acetate = 1/2); FT-IR (neat) νmax: 3479, 3456, 2939, 1697, 1651, 1620, 1481, 1412, 1381, 1188, 995, 764 cm–1; 1H NMR (500 MHz, CDCl3, δ): 10.38 (s, 1H CHO), 8.47 (d, J = 16.0 Hz, 1H, H-3), 7.95–7.87 (m, 1H, Ar), 7.70–7.58 (m, 2H, Ar), 7.57–7.50 (m, 1H, Ar), 6.95 (d, J = 16.0 Hz, 1H, H-2), 3.77 (s, 3H, OMe), 3.33 (s, 3H, NMe); 13C{1H} NMR (125 MHz, CDCl3): δ 191.3 (CHO), 166.0 (C-1), 139.3 (C-3), 137.9 (Ar), 134.0 (Ar), 133.8 (Ar), 130.8 (Ar), 129.5 (Ar), 128.1 (Ar), 121.4 (C-2), 62.0 (OMe), 32.5 (NMe); HRMS calcd for C12H13NO3Na [M + Na]+ 242.0788; found, 242.0781.
(2E,2′E)-3,3′-(1,2-Phenylene)bis(N-methoxy-N-methyl-prop-2-enamide) ((E,E)-20ac)
Rf = 0.18 (silica gel, hexane/ethyl acetate = 1/2); FT-IR (neat) νmax: 3471, 2970, 2939, 1651, 1612, 1473, 1419, 1381, 1180, 1103, 995, 980, 764 cm–1; 1H NMR (500 MHz, CDCl3, δ): 8.05 (d, J = 16.0 Hz, 2H, H-3, H-3′), 7.63–7.54 (m, 2H, Ar), 7.43–7.34 (m, 2H, Ar), 6.91 (d, J = 16.0 Hz, 2H, H-2, H-2′), 3.77 (s, 6H, OMe), 3.31 (s, 6H, NMe); 13C{1H} NMR (125 MHz, CDCl3): δ 166.4 (C-1, C-1′), 140.9 (C-3, C-3′), 135.3 (Ar), 129.3 (Ar), 128.2 (Ar), 119.9 (C-2, C-2′), 62.0 (OMe), 32.5 (NMe); HRMS calcd for C16H20N2O4Na [M + Na]+ 327.1315; found, 327.1312.
(2E,2′E)-3,3′-(1,3-Phenylene)bis(N-methoxy-N-methyl-prop-2-enamide) ((E,E)-20ad)
Rf = 0.23 (silica gel, hexane/ethyl acetate = 1/2); mp: 86.5 °C; ATR-IR νmax: 2938, 1662, 1647, 1623, 1465, 1441, 1413, 1374, 1179, 1096, 994, 794 cm–1; 1H NMR (500 MHz, CDCl3, δ): 7.75 (d, J = 16.0 Hz, 2H, H-3, H-3′), 7.74–7.69 (m, 1H, Ar), 7.63–7.54 (m, 2H, Ar), 7.45–7.38 (m, 1H, Ar), 7.07 (d, J = 16.0 Hz, 2H, H-2, H-2′), 3.79 (s, 6H, OMe), 3.33 (s, 6H, NMe); 13C{1H} NMR (125 MHz, CDCl3): δ 166.7 (C-1, C-1′), 142.7 (C-3, C-3′), 135.8 (Ar), 129.2 (Ar), 129.0 (Ar), 127.8 (Ar), 116.6 (C-2, C-2′), 61.9 (OMe), 32.5 (NMe); HRMS calcd for C16H20N2O4Na [M + Na]+ 327.1315; found, 327.1314.
(2E,2′E)-3,3′-(1,4-Phenylene)bis(N-methoxy-N-methyl-prop-2-enamide) ((E,E)-20ae)
Rf = 0.22 (silica gel, hexane/ethyl acetate = 1/2); mp: 183.6 °C; FT-IR (KBr) νmax: 3433, 2978, 2939, 1643, 1604, 1458, 1427, 1381, 1196, 1180, 995, 825 cm–1; 1H NMR (500 MHz, CDCl3, δ): 7.73 (d, J = 16.0 Hz, 2H, H-3, H-3′), 7.59 (s, 4H, Ar), 7.07 (d, J = 16.0 Hz, 2H, H-2, H-2′), 3.78 (s, 6H, OMe), 3.32 (s, 6H, NMe); 13C{1H} NMR (125 MHz, CDCl3): δ 166.7 (C-1, C-1′), 142.4 (C-3, C-3′), 136.5 (Ar), 128.4 (Ar), 116.6 (C-2, C-2′), 61.9 (OMe), 32.5 (NMe); HRMS calcd for C16H20N2O4Na [M + Na]+ 327.1315; found, 327.1308.
(2E,2′E,2″E)-3,3′,3″-(Benzene-1,3,5-triyl)tris(N-methoxy-N-methyl-prop-2-enamide) ((E,E,E)-20af)
Rf = 0.18 (silica gel, ethyl acetate); mp: 213.6 °C; ATR-IR νmax: 2964, 1654, 1615, 1472, 1448, 1416, 1386, 1181, 1000 cm–1; 1H NMR (500 MHz, CDCl3, δ): 7.76 (d, J = 16.0 Hz, 3H, H-3, H-3′, H-3″), 7.72 (s, 3H, Ar), 7.00 (d, J = 16.0 Hz, 3H, H-2, H-2′, H-2″), 3.81 (s, 9H, OMe), 3.34 (s, 9H, NMe); 13C{1H} NMR (125 MHz, CDCl3): δ 166.4 (C-1, C-1′, C-1″), 142.1 (C-3, C-3′, C-3″), 136.4 (Ar), 128.3 (Ar), 117.4 (C-2, C-2′, C-2″), 62.0 (OMe), 32.5 (NMe); HRMS calcd for C21H27N3O6Na [M + Na]+ 440.1792; found, 440.1794.
Gram-Scale Reaction of 17d
To a solution of phosphate 1 (9.57 g, 40.0 mmol) in THF (80 mL), a 2.0 M solution of isopropylmagnesium chloride in THF (18.0 mL, 36.0 mmol) was added at −78 °C. After the reaction mixture was stirred at −78 °C for 30 min, a solution of trans-cinnamaldehyde 17d (2.64 g, 20.0 mmol) in THF (20 mL) was added at room temperature, and the reaction mixture was stirred for 21 h. To the reaction mixture, saturated aqueous ammonium chloride was added at 0 °C, and the mixture was extracted with ethyl acetate. The organic layer was dried over sodium sulfate. After filtration of the mixture and concentration of the solvent, the crude mixture was purified by flash column chromatography (eluant: hexane/ethyl acetate = 4/1 to 1/1) to afford alkene (E)-18d (4.03 g, 93%) as white solid and alkene (Z)-18d (131 mg, 3.0%) as white solid.
Reduction in the Successive Elongation Process
To a solution of Weinreb amide in THF, a 1.0 M solution of diisobutylaluminum hydride in hexane was added at −78 °C, and the reaction mixture was stirred at −78 °C for Time. Since Weinreb amide remained, a 1.0 M solution of diisobutylaluminum hydride in hexane was added to the reaction mixture. After the reaction mixture stirred at −78 °C for Time, methanol and saturated aqueous Rochelle salt were added, and the mixture was stirred at room temperature. The mixture was extracted with ethyl acetate, and the organic layer was dried over sodium sulfate. After filtration of the mixture and concentration of the solvent, α,β-unsaturated aldehyde was obtained as a colorless oil and used in the next HWE reaction without further purification.
E-Selective HWE Reaction in the Successive Elongation Process
To a solution of phosphate 1 (2.0 equiv: 95.7 mg, 0.400 mmol) in THF (4.7 mL), a 2.0 M solution of isopropylmagnesium chloride in THF (1.8 equiv: 0.18 mL, 0.360 mmol) was added at −78 °C. After the reaction mixture was stirred at −78 °C for 30 min, a solution of α,β-unsaturated aldehyde in THF (2.0 mL) was added at room temperature, and the reaction mixture was stirred for Time. To the reaction mixture, saturated aqueous ammonium chloride was added at 0 °C, and the mixture was extracted with ethyl acetate. The organic layer was dried over sodium sulfate. After filtration of the mixture and concentration of the solvent, the crude mixture was purified by thin layer chromatography on silica (eluant; hexane/ethyl acetate = 1/1) to afford diene.
Z-Selective HWE Reaction in the Successive Elongation Process
To a solution of phosphate 21 (2.0 equiv: 139 mg, 0.400 mmol) and 1,4,7,10,13,16-hexaoxacyclooctadecane (3.6 equiv: 190 mg, 0.720 mmol) in THF (4.7 mL), a 1.0 M solution of potassium bis(trimethylsilyl)amide in THF (1.8 equiv: 0.36 mL, 0.360 mmol) was added at −78 °C. After the reaction mixture was stirred at −78 °C for 30 min, a solution of α,β-unsaturated aldehyde in THF (2.0 mL) was added at −78 °C, and the reaction mixture was stirred for Time. To the reaction mixture, saturated aqueous ammonium chloride was added at −78 °C, and the mixture was extracted with ethyl acetate. The organic layer was dried over sodium sulfate. After filtration of the mixture and concentration of the solvent, the crude mixture was purified by thin layer chromatography on silica (eluant; hexane/ethyl acetate = 1/1) to afford diene.
(2Z)-N-Methoxy-N-methyl-3-phenylprop-2-enamide ((Z)-20a)
Rf = 0.36 (silica gel, hexane/ethyl acetate = 2/1); FT-IR (neat) νmax: 2970, 2931, 1651, 1496, 1427, 1358, 1180, 1103, 1003, 787, 702 cm–1; 1H NMR (500 MHz, CDCl3, δ): 7.65–7.40 (m, 2H, Ar), 7.40–7.23 (m, 3H, Ar), 6.77 (d, J = 12.5 Hz, 1H, H-3), 6.28 (brd, J = 12.5 Hz, 1H, H-2), 3.65 (br s, 3H, OMe), 3.26 (br s, 3H, NMe); 13C{1H} NMR (125 MHz, CDCl3): δ 168.1 (C-1), 137.7 (C-3), 135.2 (Ar), 129.1 (Ar), 128.6 (Ar), 128.2 (Ar), 120.6 (C-2), 61.7 (OMe), 32.2 (NMe); HRMS calcd for C11H13NO2Na [M + Na]+ 214.0838; found, 214.0842.
(2E,4Z)-N-Methoxy-N-methyl-5-phenylpenta-2,4-dienamide ((2E,4Z)-18d)
Rf = 0.30 (silica gel, hexane/ethyl acetate = 2/1); FT-IR (neat) νmax: 2962, 2939, 1651, 1612, 1450, 1419, 1381, 1180, 1003, 864, 810, 702 cm–1; 1H NMR (500 MHz, C6D6, δ): 8.36 (ddd, J = 15.0, 11.5, 1.0 Hz, 1H, H-3), 7.29–7.23 (m, 2H, Ar), 7.05–6.93 (m, 3H, Ar), 6.69 (d, J = 15.0 Hz, 1H, H-2), 6.50 (dd, J = 11.5, 1.0 Hz, 1H, H-5), 6.24 (dd, J = 11.5, 11.5 Hz, 1H, H-4), 3.06 (s, 3H, OMe), 2.94 (s, 3H, NMe); 13C{1H} NMR (125 MHz, C6D6): δ 167.0 (C-1), 139.1 (C-3), 137.0 (C-5), 136.8 (Ar), 129.5 (Ar), 128.7 (Ar), 128.2 (Ar), 128.1 (C-4), 122.6 (C-2), 61.1 (OMe), 32.2 (NMe); HRMS calcd for C13H15NO2Na [M + Na]+ 240.0995; found, 240.0987.
(2Z,4Z)-N-Methoxy-N-methyl-5-phenylpenta-2,4-dienamide ((2Z,4Z)-18d)
Rf = 0.45 (silica gel, hexane/ethyl acetate = 2/1); FT-IR (neat) νmax: 2962, 2931, 1643, 1450, 1435, 1381, 1095, 802, 702 cm–1; 1H NMR (500 MHz, C6D6, δ): 8.19 (dd, J = 11.5, 11.5 Hz, 1H, H-4), 7.22–7.12 (m, 2H, Ar), 7.12–7.06 (m, 2H, Ar), 7.06–6.99 (m, 1H, Ar), 7.00 (dd, J = 11.5, 11.5 Hz, 1H, H-3), 6.63 (d, J = 11.5 Hz, 1H, H-5), 6.21 (d, J = 11.5 Hz, 1H, H-2), 3.03 (s, 3H, OMe), 2.93 (s, 3H, NMe); 13C{1H} NMR (125 MHz, C6D6): δ 167.2 (C-1), 138.1 (C-3), 137.1 (C-5), 136.7 (Ar), 129.8 (Ar), 128.4 (Ar), 127.7 (Ar), 127.2 (C-4), 118.4 (C-2), 60.9 (OMe), 31.9 (NMe); HRMS calcd for C13H15NO2Na [M + Na]+ 240.0995; found, 240.0995.
Synthesis of a Successive Biscyclopropane
To a solution of trimethylsulfoxonium iodide (2.0 equiv) in dimethyl sulfoxide, sodium hydride (55% dispersion in mineral oil) (2.0 equiv) was added at 0 °C. After the mixture was stirred at 0 °C for 30 min, a solution of alkene (1.0 equiv) in dimethyl sulfoxide was added to the mixture at 0 °C. The reaction mixture was stirred at room temperature for Time. To the reaction mixture, saturated aqueous ammonium chloride was added at 0 °C, and the mixture was extracted with ethyl acetate. The organic layer was dried over sodium sulfate. After filtration of the mixture and concentration of the solvent, the crude mixture was purified by thin layer chromatography on silica (eluant; hexane/ethyl acetate = 1/1) to afford cyclopropane.
(1SR,2SR)-N-Methoxy-N-methyl-2-phenylcyclopropane-1-carboxamide (trans-22)
Rf = 0.39 (silica gel, hexane/ethyl acetate = 2/1); ATR-IR νmax: 2936, 1653, 1462, 1441, 1422, 1369, 995, 750, 699 cm–1; 1H NMR (500 MHz, CDCl3, δ): 7.32–7.24 (m, 2H, Ar), 7.23–7.17 (m, 1H, Ar), 7.16–7.11 (m, 2H, Ar), 3.69 (s, 3H, OMe), 3.24 (s, 3H, NMe), 2.51 (ddd, J = 9.5, 6.5, 4.0 Hz, 1H, H-3), 2.47–2.35 (m, 1H, H-2), 1.63 (ddd, J = 9.5, 5.5, 4.0 Hz, 1H, CH2), 1.31 (ddd, J = 8.5, 6.5, 4.0 Hz, 1H, CH2); 13C{1H} NMR (125 MHz, CDCl3): δ 173.0 (C-1), 140.7 (Ar), 128.4 (Ar), 126.21 (Ar), 126.16 (Ar), 61.6 (OMe), 32.5 (NMe), 25.8 (C-3), 21.5 (C-2), 16.4 (CH2); HRMS calcd for C12H15NO2Na [M + Na]+ 228.0995; found, 228.0986.
(1RS,1′RS,2SR,2′SR)-N-Methoxy-N-methyl-2′-phenyl-[1,1′-bi(cyclopropane)]-2-carboxamide (trans-syn-trans-23). (1SR,1′RS,2RS,2′SR)-N-Methoxy-N-methyl-2′-phenyl-[1,1′-bi(cyclopropane)]-2-carboxamide (trans-anti-trans-23)
Mixture of trans-syn-trans-23 and trans-anti-trans-23
Rf = 0.33 (silica gel, hexane/ethyl acetate = 2/1); ATR-IR νmax: 3003, 1654, 1498, 1464, 1422, 1390, 700 cm–1.
trans-syn-trans-23 or trans-anti-trans-23
1H NMR (500 MHz, CDCl3, δ): 7.29–7.20 (m, 2H, Ar), 7.17–7.11 (m, 1H, Ar), 7.07–7.00 (m, 2H, Ar), 3.76 (s, 3H, OMe), 3.209 (s, 3H, NMe), 2.15–1.95 (m, 1H, H-2), 1.82–1.71 (m, 1H, H-2′), 1.58–1.44 (m, 1H, H-1), 1.24–1.05 (m, 2H, H-3, H-1′), 0.97–0.73 (m, 3H, H-3, H-3′); 13C{1H} NMR (125 MHz, CDCl3): δ 173.92 (CO), 142.9 (Ar), 128.28 (Ar), 125.7 (Ar), 125.48 (Ar), 61.6 (OMe), 32.6 (NMe), 24.30 (C-1′), 24.2 (C-1), 22.5 (C-2′), 16.9 (C-2), 14.7 (C-3′), 13.73 (C-3).
trans-syn-trans-23 or trans-anti-trans-23
1H NMR (500 MHz, CDCl3, δ): 7.29–7.20 (m, 2H, Ar), 7.17–7.11 (m, 1H, Ar), 7.07–7.00 (m, 2H, Ar), 3.75 (s, 3H, OMe), 3.209 (s, 3H, NMe), 2.15–1.95 (m, 1H, H-2), 1.82–1.71 (m, 1H, H-2′), 1.58–1.44 (m, 1H, H-1), 1.24–1.05 (m, 2H, H-3, H-1′), 0.97–0.73 (m, 3H, H-3, H-3′); 13C{1H} NMR (125 MHz, CDCl3): δ 173.87 (CO), 142.8 (Ar), 128.27 (Ar), 125.6 (Ar), 125.46 (Ar), 61.5 (OMe), 32.5 (NMe), 24.29 (C-1′), 24.1 (C-1), 21.8 (C-2′), 16.5 (C-2), 13.74 (C-3′), 12.9 (C-3).
Mixture of trans-syn-trans-23 and trans-anti-trans-23
HRMS calcd for C15H19NO2Na [M + Na]+ 268.1308; found, 268.1295.
HWE Reaction of Cyclohexanone (24)
To a solution of phosphate 1 (2.0 equiv: 95.7 mg, 0.400 mmol) in THF (4.7 mL), a 2.0 M solution of isopropylmagnesium chloride in THF (1.8 equiv: 0.18 mL, 0.360 mmol) was added at −78 °C. After the reaction mixture was stirred at −78 °C for 30 min, a solution of cyclohexanone 24 (1.0 equiv: 19.5 mg, 0.199 mmol) in THF (2.0 mL) was added at room temperature, and the reaction mixture was stirred for 24 h. To the reaction mixture, saturated aqueous ammonium chloride was added at 0 °C, and the mixture was extracted with ethyl acetate. The organic layer was dried over sodium sulfate. After filtration of the mixture and concentration of the solvent, the crude mixture was purified by thin layer chromatography on silica (eluant; hexane/ethyl acetate = 3/1) to afford alkene 25 (33.5 mg, 92%) as a colorless oil.
2-Cyclohexylidene-N-methoxy-N-methylacetamide (25)
Rf = 0.52 (silica gel, hexane/ethyl acetate = 2/1); FT-IR (neat) νmax: 2931, 2854, 1651, 1450, 1412, 1389, 1342, 1180, 1011, 987 cm–1; 1H NMR (500 MHz, CDCl3, δ): 6.02 (s, 1H, H-2), 3.68 (s, 3H, OMe), 3.20 (s, 3H, NMe), 2.76 (t, J = 5.5 Hz, 2H, CH2(CH2)3CH2 or CH2(CH2)3CH2), 2.22 (t, J = 5.5 Hz, 2H, CH2(CH2)3CH2 or CH2(CH2)3CH2), 1.72–1.53 (m, 6H, CH2CH2CH2CH2CH2); 13C{1H} NMR (125 MHz, CDCl3): δ 168.1 (C-1), 159.9 (C-3), 111.5 (C-2), 61.3 (OMe), 38.2 (CH2(CH2)3CH2 or CH2(CH2)3CH2), 32.1 (NMe), 30.0 (CH2(CH2)3CH2 or CH2(CH2)3CH2), 28.7 (CH2CH2(CH2)3 or (CH2)3CH2CH2), 27.8 (CH2CH2(CH2)3 or (CH2)3CH2CH2), 26.3 ((CH2)2CH2(CH2)2); HRMS calcd for C20H34N2O4Na [2 M + Na]+ 389.2411; found, 389.2420.
Weinreb Ketone Synthesis
To a solution of Weinreb amide syn-16p (or anti-16q) (1.0 equiv: 0.100 mmol) in THF (2.0 mL), a 1.04 M solution of methylmagnesium bromide in THF (0.19 mL, 0.200 mmol) was added at −78 °C. After the rection mixture was stirred at −78 °C for 10 min, the reaction mixture was stirred at 0 °C for 30 min. To the reaction mixture, saturated aqueous ammonium chloride was added at 0 °C, and the mixture was extracted with ethyl acetate. The organic layer was dried over sodium sulfate. After filtration of the mixture and concentration of the solvent, the crude mixture was purified by thin layer chromatography on silica (eluant; hexane/ethyl acetate = 6/1) to afford ketone.
(5RS,6SR,3E)-6-((tert-Butyldimethylsilyl)oxy)-5-methyl-6-phenylhex-3-en-2-one (syn-26)
Rf = 0.96 (silica gel, hexane/ethyl acetate = 2/1); FT-IR (neat) νmax: 2954, 2931, 2885, 2854, 1674, 1365, 1257, 1088, 1065, 864, 841, 779, 702 cm–1; 1H NMR (500 MHz, CDCl3, δ): 7.34–7.19 (m, 5H, Ar), 6.73 (dd, J = 16.0, 7.5 Hz, 1H, H-3), 5.96 (dd, J = 16.0, 1.0 Hz, 1H, H-2), 4.61 (dd, J = 6.5, 0.5 Hz, 1H, H-5), 2.60 (dqdd, J = 7.5, 7.0, 6.5, 1.0 Hz, 1H, H-4), 2.19 (s, 3H, COCH3), 1.02 (d, J = 7.0 Hz, 3H, 4-Me), 0.90 (s, 9H, TBS), 0.02 (s, 3H, TBS), −0.20 (s, 3H, TBS); 13C{1H} NMR (125 MHz, CDCl3): δ 198.7 (C-1), 150.6 (C-3), 142.7 (Ar), 131.0 (C-2), 127.9 (Ar), 127.3 (Ar), 126.4 (Ar), 77.8 (C-5), 45.4 (C-4), 26.6 (COCH3), 25.8 (TBS), 18.2 (TBS), 13.9 (4-Me), −4.6 (TBS), −5.2 (TBS); HRMS calcd for C19H30O2SiNa [M + Na]+ 341.1907; found, 341.1905.
(5SR,6SR,3E)-6-((tert-Butyldimethylsilyl)oxy)-5-methyl-6-phenylhex-3-en-2-one (anti-26)
Rf = 0.94 (silica gel, hexane/ethyl acetate = 2/1); FT-IR (neat) νmax: 2954, 2931, 2893, 2854, 1674, 1365, 1257, 1088, 1065, 841, 779, 702 cm–1; 1H NMR (500 MHz, CDCl3, δ): 7.34–7.21 (m, 5H, Ar), 6.86 (dd, J = 16.0, 8.0 Hz, 1H, H-3), 5.97 (dd, J = 16.0, 1.0 Hz, 1H, H-2), 4.48 (d, J = 6.0 Hz, 1H, H-5), 2.59 (dqdd, J = 8.0, 7.0, 6.0, 1.0 Hz, 1H, H-4), 2.23 (s, 3H, COCH3), 0.94 (d, J = 7.0 Hz, 3H, 4-Me), 0.87 (s, 9H, TBS), 0.01 (s, 3H, TBS), −0.24 (s, 3H, TBS); 13C{1H} NMR (125 MHz, CDCl3): δ 198.8 (C-1), 150.6 (C-3), 143.0 (Ar), 131.3 (C-2), 128.0 (Ar), 127.4 (Ar), 126.6 (Ar), 78.8 (C-5), 45.6 (C-4), 26.0 (COCH3), 25.7 (TBS), 18.1 (TBS), 16.0 (4-Me), −4.6 (TBS), −5.1 (TBS); HRMS calcd for C19H30O2SiNa [M + Na]+ 341.1907; found, 341.1908.
Data Availability Statement
The data underlying this study are available in the published article and its Supporting Information.
Supporting Information Available
The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acs.joc.4c01140.
Experimental procedures, compounds data, NMR spectra (PDF)
Author Contributions
† T.M. and H.T. have contributed equally. The manuscript was written through contributions of all authors. All authors have given approval to the final version of the manuscript.
This study was supported by JST, the establishment of university fellowships toward the creation of science technology innovation, grant number JPMJFS2144 and a SUNBOR Grant from the Suntory Foundation for Life Sciences.
The authors declare no competing financial interest.
Supplementary Material
References
- Horner L.; Hoffmann H. M. R.; Wippel H. G. Phosphororganische Verbindungen, XII. Phosphinoxyde als Olefinierungsreagenzien. Chem. Ber. 1958, 91, 61–63. 10.1002/cber.19580910113. [DOI] [Google Scholar]
- Wadsworth W. S. Jr.; Emmons W. D. The Utility of Phosphonate Carbanions in Olefin Synthesis. J. Am. Chem. Soc. 1961, 83, 1733–1738. 10.1021/ja01468a042. [DOI] [Google Scholar]
- For the representative HWE reagents, see:; a Kosolapoff G. M.; Powell J. S. Alkylation of Triethyl Phosphonoacetate and Related Esters. J. Am. Chem. Soc. 1950, 72, 4198–4200. 10.1021/ja01165a104. [DOI] [Google Scholar]; b Dawson N. D.; Burger A. Some Alkyl Thiazolephosphonates. J. Am. Chem. Soc. 1952, 74, 5312–5314. 10.1021/ja01141a025. [DOI] [Google Scholar]; c Elbert C. L.Alkyl esters of phosphono bis beta cyanoethyl acetic acid and acetic acid nitrile. U.S. Patent 2,632,019 A, 1953.; d Lutsenko I. F.; Kirilov M. Phosphorylation of chlorovinylketones. Primary products formed in the reaction of phosphorus pentachloride with enolacetates. Dokl. Akad. Nauk SSSR 1960, 132, 842–845. [Google Scholar]; e Stilz W.; Pommer H.. Process for the production of α, β-unsaturated nitriles. DE 1108208 B. 1961.; f Ramirez F.; Yamanaka H.; Basedow O. H. New Reactions of Phosphite Esters: The Conversion of Phthalic Anhydride into Biphthalyl by Trialkyl Phosphites and into Phthalide-3-phosphonates by Dialkyl Phosphites1. J. Am. Chem. Soc. 1961, 83, 173–178. 10.1021/ja01462a034. [DOI] [Google Scholar]; g Speziale A. J.; Mo K.. Process for Producing Dialkyl (carbamoylmethyl)phosphonates. U.S. Patent 3,066,140 A. November 27, 1962.; h Hans M.; Richard W. Organic Fluorine Compounds. IV. Carbonyl Fluoroolefination. Liebigs Ann. Chem. 1964, 674, 1–10. [Google Scholar]; i Martin D. J.; Griffin C. E. The Determination of Polar Substituent Constants for the Dialkoxy- and Diaryl Phosphono and Trialkyl- and Triarylphosphonium Groups. J. Org. Chem. 1965, 30, 4034–4038. 10.1021/jo01023a011. [DOI] [Google Scholar]; j Groß H.; Freiberg J. Synthesis with Methoxychloroacetic Acid Methyl Esters. Angew. Chem. 1965, 77, 1022. [Google Scholar]; k Grell W.; Machleidt H. Synthesen mit phosphororganischen Verbindungen, I. Esterolefinierungen. Liebigs Ann. Chem. 1966, 693, 134–157. 10.1002/jlac.19666930113. [DOI] [PubMed] [Google Scholar]; l Grell W.; Machleidt H. Synthesen mit phosphororganischen Verbindungen, II. PO-Aktivierte Alkoxyolefinierung. Liebigs Ann. Chem. 1966, 699, 53–67. 10.1002/jlac.19666990106. [DOI] [PubMed] [Google Scholar]; m Nagata W.; Hayase Y. Formylolefination of Carbonyl Compounds. Tetrahedron Lett. 1968, 9, 4359–4362. 10.1016/s0040-4039(01)99131-2. [DOI] [Google Scholar]; n Nagata W.; Hayase Y.. 2-Hydrocarbyl Aminovinyl Phosphonates or Phosphinates. U.S. Patent 3,673,284 A, 1972.; o Eberlein W.; Nickl J.; Heider J.; Dahms G.; Machleidt H. Steroidische Cardiotonica, I Einführung von Substituenten in den Butenolid-Ring von Herzglykosiden. Chem. Ber. 1972, 105, 3686–3694. 10.1002/cber.19721051122. [DOI] [PubMed] [Google Scholar]; p Yoffe S.; Petrovsky P. V.; Goryunov Y. I.; Yershova T. V.; Kabachnik M. I. The Aldo-cis-trans-enoic Equilibrium of Substituted Alkyl Formylacetates and Alkyl Formylmethylphosphonates. Tetrahedron 1972, 28, 2783–2798. 10.1016/0040-4020(72)80114-5. [DOI] [Google Scholar]; q Ratcliffe R. W.; Christensen B. G. Total synthesis of β-lactam antibiotics I. : α-thioformamido-diethylphosphonoacetates. Tetrahedron Lett. 1973, 46, 4645–4648. [Google Scholar]; r Dinizo S. E.; Freerksen R. W.; Pabst W. E.; Watt D. S. Synthesis of .alpha.-alkoxyacrylonitriles using substituted diethyl cyanomethylphosphonates. J. Org. Chem. 1976, 41, 2846–2849. 10.1021/jo00879a011. [DOI] [Google Scholar]; s Badar Y.; Chopra A. K.; Dias H. W.; Hursthouse M. B.; Khokhar A. R.; Ito M.; Toube T. P.; Weedon B. C. L. Pyrrolylpolyenes. Part 2. Stereochemistry of Wallemia A and Synthesis of Its (E)-Isomer and Other Models. J. Chem. Soc., Perkin Trans. 1 1977, 1977, 1372–1376. 10.1039/p19770001372. [DOI] [Google Scholar]; t Kluge A. F.; Cloudsdale I. S. Phosphonate Reagents for the Synthesis of Enol Ethers and One-Carbon Homologation to Aldehydes. J. Org. Chem. 1979, 44, 4847–4852. 10.1021/jo00394a022. [DOI] [Google Scholar]; u Evans D. A.; Hurst K. M.; Takacs J. M. New Silicon–Phosphorus Reagents in Organic Synthesis. Carbonyl and Conjugate Addition Reactions of Silicon Phosphite Esters and Related Systems. J. Am. Chem. Soc. 1978, 100, 3467–3477. 10.1021/ja00479a031. [DOI] [Google Scholar]; v Motoyoshiya J.; Yamamoto I.; Gotoh H. Synthesis and Reactions of C-Sulphenylketenimines. J. Chem. Soc., Perkin Trans. 1 1981, 1981, 2727–2730. 10.1039/p19810002727. [DOI] [Google Scholar]; w Still W. C.; Gennari C. Direct Synthesis of Z-Unsaturated Esters. A Useful Modification of the Horner–Emmons Olefination. Tetrahedron Lett. 1983, 24, 4405–4408. 10.1016/S0040-4039(00)85909-2. [DOI] [Google Scholar]; x Schmidt U.; Lieberknecht A.; Schanbacher U.; Beuttler T.; Wild J. AMINO ACIDS AND PEPTIDES. PART 36. DEHYDROAMINO ACIDS. PART 16. SIMPLE PREPARATION OF N-ACYL-2-(DIETHOXYPHOSPHORYL)GLYCINE ESTERS AND THEIR APPLICATION IN THE SYNTHESIS OF DEHYDROAMINO ACID ESTERS. Chemischer Informationsdienst 1983, 14, 158–159. 10.1002/chin.198302310. [DOI] [Google Scholar]; y Schultz A. G.; Napier J. J.; Ravichandran R. Synthetic Applications of Heteroatom-Directed Photoarylation. Benzo[b]furan Ring Construction. J. Org. Chem. 1983, 48, 3408–3412. 10.1021/jo00168a008. [DOI] [Google Scholar]; z Taguchi T.; Mitsuhashi S.; Yamanouchi A.; Kobayashi Y.; Sai H.; Ikekawa N. Synthesis of 23,23-Difluoro-25-hydroxyvitamin D3. Tetrahedron Lett. 1984, 25, 4933–4936. 10.1016/S0040-4039(01)91262-6. [DOI] [Google Scholar]; aa Marshall J. A.; Trometer J. D.; Cleary D. G. Stereoselective SN2’ additions of organocuprates to homochiral acyclic vinyloxiranes. Tetrahedron 1989, 45, 391–402. 10.1016/0040-4020(89)80067-5. [DOI] [Google Scholar]; ab Tessier J.; Demoute J.-P.; Truong V. T.. Process for the Preparation of Fluorinated Derivatives of Phosphonic Acid. EP 0224417 B1, 1987.; ac Mikołajczyk M.; Midura W. H. Diethyl α-(Methylthio)phosphonoacetic Acid: A New Bifunctional Reagent. Synthesis of Unsaturated Five- and Six-Membered Lactones. Synlett 1991, 1991, 245–247. 10.1055/s-1991-20694. [DOI] [Google Scholar]; ad Röhr G.; Schnell M.; Köckritz A. α-Substituted Phosphonates; 61.1Synthesis of 2-Phosphonoglycine Amides by Solvolysis of 5-Amino-4-phosphonooxazoles. Synthesis 1992, 1992, 1031–1034. 10.1055/s-1992-26294. [DOI] [Google Scholar]; ae Schmidt U.; Langner J.; Kirschbaum B.; Braun C. Synthesis and Enantioselective Hydrogenation of α-Acyloxyacrylates. Synthesis 1994, 1994, 1138–1140. 10.1055/s-1994-25656. [DOI] [Google Scholar]; af Cox G. G.; Miller D. J.; Moody C. J.; Sie E.-R. H. B.; Kulagowski J. J. Rhodium-carbenoid mediated O-H insertion reactions. O-H insertion vs. H-abstraction and effect of catalyst. Tetrahedron 1994, 50, 3195–3212. 10.1016/S0040-4020(01)81117-0. [DOI] [Google Scholar]; ag Ando K. Practical Synthesis of Z-Unsaturated Esters by Using a New Horner–Emmons Reagent, Ethyl Diphenylphosphonoacetate. Tetrahedron 1995, 36, 4105–4108. 10.1016/0040-4039(95)00726-S. [DOI] [Google Scholar]; ah Boumendjel A.; Nuzillard J.-M.; Massiot G. Synthesis of ajmalicine derivatives using Wittig–Horner and Knoevenagel reactions. Tetrahedron Lett. 1999, 40, 9033–9036. 10.1016/S0040-4039(99)01921-8. [DOI] [Google Scholar]; ai Iorga B.; Ricard L.; Savignac P. Carbanionic displacement reactions at phosphorus. Part III. Cyanomethylphosphonate vs. cyanomethylenediphosphonate. Synthesis and solid-state structures. J. Chem. Soc., Perkin Trans. 1 2000, 2000, 3311–3316. 10.1039/b003371p. [DOI] [Google Scholar]; aj Ando K. Preparations of Z-α,β-Unsaturated Amides by Using Horner-Wadsworth-Emmons Reagents, (Diphenylphosphono)acetamides. Synlett 2001, 2001, 1272–1274. 10.1055/s-2001-16072. [DOI] [Google Scholar]; ak Vanderwal C. D.; Vosburg D. A.; Sorensen E. J. Intramolecular Allenolate Acylations in Studies toward a Synthesis of FR182877. Org. Lett. 2001, 3, 4307–4310. 10.1021/ol016994v. [DOI] [PubMed] [Google Scholar]; al Fortin S.; Dupont F.; Deslongchamps P. A New Bis(2,2,2-trifluoroethyl)phosphonate for the Synthesis of Z-Unsaturated N-Methoxy-N-methylamides. J. Org. Chem. 2002, 67, 5437–5439. 10.1021/jo025816s. [DOI] [PubMed] [Google Scholar]; am Nagamitsu T.; Takano D.; Fukuda T.; Otoguro K.; Kuwajima I.; Harigaya Y.; O̅mura S. Total Synthesis of (−)-Borrelidin. Org. Lett. 2004, 6, 1865–1867. 10.1021/ol049356w. [DOI] [PubMed] [Google Scholar]
- For the representative examples of HWE reaction in organic syntheses, see the following reviews and references therein:; a Bisceglia J. A. ´.; Orelli L. R. Recent Application of the Horner–Wadsworth–Emmons Reaction to the Synthesis of Natural Products. Curr. Org. Chem. 2012, 16, 2206–2230. 10.2174/138527212803520227. [DOI] [Google Scholar]; b Kobayashi K.; Tanaka K. III; Kogen H. Recent topics of the natural product synthesis by Horner–Wadsworth–Emmons reaction. Tetrahedron Lett. 2018, 59, 568–582. 10.1016/j.tetlet.2017.12.076. [DOI] [Google Scholar]; c Janicki I.; Kiełbasiński P. Still–Gennari Olefination and its Applications in Organic Synthesis. Adv. Synth. Catal. 2020, 362, 2552–2596. 10.1002/adsc.201901591. [DOI] [Google Scholar]; d Beemelmanns C.; Roman D.; Sauer M. Applications of the Horner–Wadsworth–Emmons Olefination in Modern Natural Product Synthesis. Synthesis 2021, 53, 2713–2739. 10.1055/a-1493-6331. [DOI] [Google Scholar]; e Bilska-Markowska M.; Kaźmierczak M. Horner–Wadsworth–Emmons reaction as an excellent tool in the synthesis of fluoro-containing biologically important compounds. Org. Biomol. Chem. 2023, 21, 1095–1120. 10.1039/D2OB01969H. [DOI] [PubMed] [Google Scholar]
- a Nahm S.; Weinreb S. M. N-methoxy-n-methyl amides as effective acylating agents. Tetrahedron Lett. 1981, 22, 3815–3818. 10.1016/S0040-4039(01)91316-4. [DOI] [Google Scholar]; b Aidhen I.; Balasubramaniam S. The Growing Synthetic Utility of the Weinreb Amide. Synthesis 2008, 2008, 3707–3738. 10.1055/s-0028-1083226. [DOI] [Google Scholar]
- Nuzillard J.-M.; Boumendjel A.; Massiot G. A new synthesis of α,β-unsaturated aldehydes. Tetrahedron Lett. 1989, 30, 3779–3780. 10.1016/S0040-4039(01)80653-5. [DOI] [Google Scholar]
- Netz D.; Seidel J. L. Diethyl (N-Methoxy-N-methylcarbamoylmethyl)phosphonate – A Useful Emmons-Horner Wittig Reagent. Tetrahedron Lett. 1992, 33, 1957–1958. 10.1016/0040-4039(92)88112-I. [DOI] [Google Scholar]
- Claridge T. D. W.; Davies S. G.; Lee J. A.; Nicholson R. L.; Roberts P. M.; Russell A. J.; Smith A. D.; Toms S. M. Highly (E)-Selective Wadsworth–Emmons Reactions Promoted by Methylmagnesium Bromide. Org. Lett. 2008, 10, 5437–5440. 10.1021/ol802212e. [DOI] [PubMed] [Google Scholar]
- The pioneering work of cation, temperature, and solvent effects in HWE reaction of ester-type HWE reagent had been reported in 1990, by Heathcock and co-workers as the following reference:Thompson S. K.; Heathcock C. H. Effect of Cation, Temperature, and Solvent on the Stereoselectivity of the Horner–Emmons Reaction of Trimethyl Phosphonoacetate with Aldehydes. J. Org. Chem. 1990, 55, 3386–3388. 10.1021/jo00297a076. [DOI] [Google Scholar]
- Other experimental data on aliphatic aldehydes, which are epimerizable aldehydes, are shown in Supporting Information. Those substrates were epimerized in the Nuzillard’s conditions. See details in Supporting Information.
- Our previous works in which LHMDS was used as deprotonation of HWE reagent for (E)-selective olefination, are shown as the following references:; a Shiina I.; Umezaki Y.; Ohashi Y.; Yamazaki Y.; Dan S.; Yamori T. Total Synthesis of AMF-26, an Antitumor Agent for Inhibition of the Golgi System, Targeting ADP-Ribosylation Factor 1. J. Med. Chem. 2013, 56, 150–159. 10.1021/jm301695c. [DOI] [PubMed] [Google Scholar]; b Shiina I.; Umezaki Y.; Murata T.; Suzuki K.; Tonoi T. Asymmetric Total Synthesis of (+)-Coprophilin. Synthesis 2018, 50, 1301–1306. 10.1055/s-0036-1591866. [DOI] [Google Scholar]; c Murata T.; Tsutsui H.; Yoshida T.; Kubota H.; Hiraishi S.; Natsukawa H.; Suzuki Y.; Hiraga D.; Mori T.; Maekawa Y.; Tateyama S.; Toyoyama K.; Ito K.; Suzuki K.; Yonekura K.; Shibata N.; Sato T.; Tasaki Y.; Inohana T.; Takano A.; Egashira N.; Honda M.; Umezaki Y.; et al. First Total Synthesis of Tanzawaic Acid B. ACS Omega 2023, 8, 27703–27709. 10.1021/acsomega.3c03634. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Blanchette M. A.; Choy W.; Davis J. T.; Essenfeld A. P.; Masamune S.; Roush W. R.; Sakai T. Horner–Wadsworth–Emmons reaction: Use of lithium chloride and an amine for base-sensitive compounds. Tetrahedron Lett. 1984, 25, 2183–2186. 10.1016/S0040-4039(01)80205-7. [DOI] [Google Scholar]
- The effect of magnesium (II) cation was pioneered by two groups of contribution. Rathke reported that the magnesium ion mediated Masamune–Roush conditions between aldehydes and triethyl phosphonoacetate give (E)-olefin. Sano, Nagao, and co-workers reported that isopropylmagnesium bromide initiating HWE reaction between aldehydes and 2-fluoro-2-diethylphosphonoacetate initiated gives (E)-olefin. See the following two group’s references:; a Rathke M. W.; Nowak M. The Horner–Wadsworth–Emmons Modification of the Wittig Reaction Using Triethylamine and Lithium or Magnesium Salts. J. Org. Chem. 1985, 50, 2624–2626. 10.1021/jo00215a004. [DOI] [Google Scholar]; b Sano S.; Ando T.; Yokoyama K.; Nagao Y. New Reaction Mode of the Horner-Wadsworth-Emmons Reaction for the Preparation of α-Fluoro-α,β-unsaturated Esters. Synlett 1998, 1998, 777–779. 10.1055/s-1998-1780. [DOI] [Google Scholar]
- Strzalko T.; Seyden-Penne J.; Froment F.; Corset J.; Simonnin M. P. Formation of Phosphonoacetate Carbanions by Lithiated Bases or by the Conjunction of a Lithium Salt and an Amine: Structural Study of Intermediate Species. J. Chem. Soc., Perkin Trans. 2 1987, 783–789. 10.1039/p29870000783. [DOI] [Google Scholar]
- Thomas L. C.; Chittenden R. A. Characteristic infra-red absorption frequencies of organophosphorus compounds—V. Spectrochim. Acta 1965, 21, 1905–1914. 10.1016/0371-1951(65)80238-7. [DOI] [Google Scholar]
- The experimental results of the isolated lithium phosphonoenolate inducing Horner–Wadsworth–Emmons reaction are shown in Supporting Information. See Supporting Information for details.
- The crystallization of isolable phosphonoenolate is under investigation. The detailed experimental results of the isolated phosphonoenolate inducing Horner–Wadsworth–Emmons reaction, are also shown in Supporting Information. See Supporting Information for details.
- The short time data of α-bromocinnamaldehyde is shown in Supporting Information. See Supporting Information for details.
- a Patrick J. B.; Williams R. P.; Webb J. S. Pimaricin II. The Structure of Pimaricin. J. Am. Chem. Soc. 1958, 80, 6689. 10.1021/ja01557a060. [DOI] [Google Scholar]; b Ceder O.; Ryhage R.; Rodmar S.; Nihlgård B.; Nilsson L. The Structure of Filipin. Acta Chem. Scand. 1964, 18, 558–560. 10.3891/acta.chem.scand.18-0558. [DOI] [Google Scholar]; c Mechlinski W.; Schaffner C. P.; Ganis P.; Avitabile G. Structure and Absolute Configuration of the Polyene Macrolide Antibiotic Amphotericin B. Tetrahedron Lett. 1970, 11, 3873–3876. 10.1016/s0040-4039(01)98612-5. [DOI] [Google Scholar]; d Falkowski L.; Golik J.; Zielinski J.; Borowski E. The Structure of Rimocidin. J. Antibiot. 1976, 29, 197–198. 10.7164/antibiotics.29.197. [DOI] [PubMed] [Google Scholar]; e Kakinuma K.; Ikekawa N.; Nakagawa A.; O̅mura S. The Structure of Asukamycin, a Possible Shunt Metabolite from 3-Dehydroquinic Acid in the Shikimate Pathway. J. Am. Chem. Soc. 1979, 101, 3402–3404. 10.1021/ja00506a056. [DOI] [Google Scholar]; f Sterner O.; Steffan B.; Steglich W. Novel azepine derivatives from the pungent mushroom. Tetrahedron 1987, 43, 1075–1082. 10.1016/S0040-4020(01)90044-4. [DOI] [Google Scholar]; g Pawlak J.; Sowiński J.; Borowski E. Streostructure of Perimycin A. J. Antibiot. 1995, 48, 1034–1038. 10.7164/antibiotics.48.1034. [DOI] [PubMed] [Google Scholar]; h Hosoe T.; Fukushima K.; Takizawa K.; Miyaji M.; Kawai K. Three pyrrolyloctatetraenyl-α-pyrones from Auxarthron conjugatum. Phytochemistry 1999, 52, 459–463. 10.1016/S0031-9422(99)00237-X. [DOI] [Google Scholar]; i Thirsk C.; Whiting A. Polyene natural products. J. Chem. Soc., Perkin Trans. 1 2002, 2002, 999–1023. 10.1039/b109741p. [DOI] [Google Scholar]; j Ishii T.; Nonaka K.; Iwatsuki M.; Masuma R.; O̅mura S.; Shiomi K. Virgaricin produced by Virgaria sp. FKI-4860. J. Antibiot. 2012, 65, 139–141. 10.1038/ja.2011.123. [DOI] [PubMed] [Google Scholar]; k Kaifuchi S.; Mori M.; Nonaka K.; Masuma R.; O̅mura S.; Shiomi K. Ukulactone C, a new NADH-fumarate reductase inhibitor produced by Talaromyces sp. FKI-6713. J. Gen. Appl. Microbiol. 2015, 61, 57–62. 10.2323/jgam.61.57. [DOI] [PubMed] [Google Scholar]
- a Andrews A. G.; Jenkins C. L.; Starr M. P.; Shepherd J.; Hope H. Structure of Xanthomonadin I, a Novel Dibrominated Aryl-polyene Pigment Produced by the Bacterium Xanthomonas Juglandis. Tetrahedron Lett. 1976, 45, 4023–4024. [Google Scholar]; b Aririatu L. E.; Kester A. S. Isolation and Characterization of the Pigment Esters of Xanthomonas juglandis (campestris). J. Gen. Microbiol. 1985, 131, 2047–2052. 10.1099/00221287-131-8-2047. [DOI] [Google Scholar]; c Sakai N.; Decatur J.; Nakanishi K.; Eldred G. E. Ocular Age Pigment “A2-E”: An Unprecedented Pyridinium Bisretinoid. J. Am. Chem. Soc. 1996, 118, 1559–1560. 10.1021/ja953480g. [DOI] [Google Scholar]; d Aulinger K.; Best H.; Spiteller P.; Spiteller M.; Steglich W. Melanocrocin, a Polyene Pigment from Melanogaster broomeianus (Basidiomycetes). Z. Naturforsch. 2001, 56c, 495–498. 10.1515/znc-2001-7-803. [DOI] [PubMed] [Google Scholar]; e Weber R. W. S.; Mucci A.; Davoli P. Laetiporic acid, a new polyene pigment from the wood-rotting basidiomycete Laetiporus sulphureus (Polyporales, Fungi). Tetrahedron Lett. 2004, 45, 1075–1078. 10.1016/j.tetlet.2003.11.073. [DOI] [Google Scholar]; f Davoli P.; Mucci A.; Schenetti L.; Weber R. W. S. Laetiporic acids, a family of non-carotenoid polyene pigments from fruit-bodies and liquid cultures of Laetiporus sulphureus (Polyporales, Fungi). Phytochemistry 2005, 66, 817–823. 10.1016/j.phytochem.2005.01.023. [DOI] [PubMed] [Google Scholar]; g Rosa-Fraile M.; Rodríguez-Granger J.; Haidour-Benamin A.; Cuerva J. M.; Sampedro A. Granadaene: Proposed Structure of the Group B Streptococcus Polyenic Pigment. Appl. Environ. Microbiol. 2006, 72, 6367–6370. 10.1128/aem.00756-06. [DOI] [PMC free article] [PubMed] [Google Scholar]; h Jaeger J. R.; Spiteller P. Mycenaaurin A, an Antibacterial Polyene Pigment from the Fruiting Bodies of Mycena aurantiomarginata. J. Nat. Prod. 2010, 73, 1350–1354. 10.1021/np100155z. [DOI] [PubMed] [Google Scholar]
- a Takizawa H.; Akiba M.; Tani T.; Kawamata J.. Non-resonant two-photon absorption material, non-resonant two-photon luminescent material, non-resonant two-photon absorption inducing method and luminescence generation method using them. JP 2004123668 A, 2004.; b Alander J. T.; Kaartinen I.; Laakso A.; Pätilä T.; Spillmann T.; Tuchin V. V.; Venermo M.; Välisuo P. A Review of Indocyanine Green Fluorescent Imaging in Surgery. Int. J. Biomed. Imaging 2012, 2012, 1–26. 10.1155/2012/940585. [DOI] [PMC free article] [PubMed] [Google Scholar]; c Kiyama M.; Iwano S.; Otsuka S.; Lu S. W.; Obata R.; Miyawaki A.; Hirano T.; Maki S. A. Quantum yield improvement of red-light-emitting firefly luciferin analogues for in vivo bioluminescence imaging. Tetrahedron 2018, 74, 652–660. 10.1016/j.tet.2017.11.051. [DOI] [Google Scholar]; d Wang S.; Fan Y.; Li D.; Sun C.; Lei Z.; Lu L.; Wang T.; Zhang F. Anti-quenching NIR-II molecular fluorophores for in vivo high-contrast imaging and pH sensing. Nat. Commun. 2019, 10, 1058. 10.1038/s41467-019-09043-x. [DOI] [PMC free article] [PubMed] [Google Scholar]; e Li Y.; Lan H.; Yan X.; Shi X.; Liu X.; Xiao S. Retinal-based polyene fluorescent probe for selectively detection of Cu2+ in physiological saline and serum. Spectrochim. Acta, Part A 2020, 227, 117565. 10.1016/j.saa.2019.117565. [DOI] [PubMed] [Google Scholar]; f Kamiya G.; Kitada N.; Saito-Moriya R.; Obata R.; Iwano S.; Miyawaki A.; Hirano T.; Maki S. A. Development of Phenyl Oligoene-type Firefly Luciferin Analogues with Extended π-Electronic Conjugation for Near-infrared Bioluminescence. Chem. Lett. 2021, 50, 1523–1525. 10.1246/cl.210261. [DOI] [Google Scholar]; g Swamy M. M. M.; Murai Y.; Monde K.; Tsuboi S.; Jin T. Shortwave-Infrared Fluorescent Molecular Imaging Probes Based on π-Conjugation Extended Indocyanine Green. Bioconjugate Chem. 2021, 32, 1541–1547. 10.1021/acs.bioconjchem.1c00253. [DOI] [PubMed] [Google Scholar]; h Zhang X.; Li S.; Ma H.; Wang H.; Zhang R.; Zhang X.-D. Activatable NIR-II organic fluorescent probes for bioimaging. Theranostics 2022, 12, 3345–3371. 10.7150/thno.71359. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hurem D.; Mcnulty J.. Phosphorus Reagents for Two-, Three-, and Four-Carbon Homologation of Carbonyl Compounds to Functionalized Olefins. In Homologation Reactions, 2nd ed.; John Wiley & Sons, 2023; pp 401–427. [Google Scholar]
- Pietruszka J. Synthesis and Properties of Oligocyclopropyl-Containing Natural Products and Model Compounds. Chem. Rev. 2003, 103, 1051–1070. 10.1021/cr010027g. [DOI] [PubMed] [Google Scholar]
- a Yoshida M.; Ezaki M.; Hashimoto M.; Yamashita M.; Shigematsu N.; Okuhara M.; Kohsaka M.; Horikoshi K. A novel antifungal antibiotic, FR-900848. I. Production, isolation, physico-chemical and biological properties. J. Antibiot. 1990, 43, 748–754. 10.7164/antibiotics.43.748. [DOI] [PubMed] [Google Scholar]; b Barrett A. G. M.; Kasdorf K. Total synthesis of the antifungal agent FR-900848. Chem. Commun. 1996, 325–326. 10.1039/cc9960000325. [DOI] [Google Scholar]; c Falck J. R.; Mekonnen B.; Yu J.; Lai J.-Y. Synthesis of the Polycyclopropane Antibiotic FR-900848 via the Horeau Gambit. J. Am. Chem. Soc. 1996, 118, 6096–6097. 10.1021/ja961093g. [DOI] [Google Scholar]; d Fu Y.; Estoppey D.; Roggo S.; Pistorius D.; Fuchs F.; Studer C.; Ibrahim A. S.; Aust T.; Grandjean F.; Mihalic M.; Memmert K.; Prindle V.; Richard E.; Riedl R.; Schuierer S.; Weber E.; Hunziker J.; Petersen F.; Tao J.; Hoepfner D. Jawsamycin exhibits in vivo antifungal properties by inhibiting Spt14/Gpi3-mediated biosynthesis of glycosylphosphatidylinositol. Nat. Commun. 2020, 11, 3387. 10.1038/s41467-020-17221-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- a Kuo M. S.; Zielinsk R. J.; Cialdella J. I.; Marschke C. K.; Dupuis M. J.; Li G. P.; Kloosterman D. A.; Spilman C. H.; Marshall V. P. Discovery, Isolation, Structure Elucidation, and Biosynthesis of U-106305, a Chlesteryl Ester Transfer Protein Inhibitor from UC 11136. J. Am. Chem. Soc. 1995, 117, 10629–10634. 10.1021/ja00148a004. [DOI] [Google Scholar]; b Charette A. B.; Lebel H. Enantioselective Total Synthesis of (+)-U-106305. J. Am. Chem. Soc. 1996, 118, 10327–10328. 10.1021/ja9619420. [DOI] [Google Scholar]; c Barrett A. G. M.; Hamprecht D.; White A. J. P.; Williams D. J. Total Synthesis and Stereochemical Assignment of the Quinquecyclopropane-Containing Cholesteryl Ester Transfer Protein Inhibitor U-106305. J. Am. Chem. Soc. 1996, 118, 7863–7864. 10.1021/ja961399n. [DOI] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
The data underlying this study are available in the published article and its Supporting Information.



















